Enthesopathies of lower limb, excluding foot

M13_ENTESOPATHYLOW

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M76 Cause of death: ICD-10 — M76 2 out of 7 registries used, show all original rules.	10162
4. Check minimum number of events None	10162
5. Include endpoints M13_GLUTEALTEND M13_PSOASTEND M13_ILIACCRESTSPUR M13_ILIOTIBBAND M13_TIBIALCOLLATERAL M13_PATELLARTEND M13_ACHILLESTEND M13_PERONEALTEND M13_ENTESOPATHYLOWNAS	10624
6. Filter based on genotype QC (FinnGen only)	10624

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M70-M79
Name in latin: Enthesopathiae membri inferioris pede excepto

NAME	M13_ENTESOPATHYLOW
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_GLUTEALTEND\|M13_PSOASTEND\|M13_ILIACCRESTSPUR\|M13_ILIOTIBBAND\|M13_TIBIALCOLLATERAL\|M13_PATELLARTEND\|M13_ACHILLESTEND\|M13_PERONEALTEND\|M13_ENTESOPATHYLOWNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M76
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M76
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Enthesopathies of lower limb, excluding foot based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	63535	34055	29249
Only index persons	61590	33269	28321
Unadjusted period prevalence (%)
Whole population	0.90	0.98	0.82
Only index persons	1.16	1.22	1.08
Median age at first event (years)
Whole population	47.77	50.98	44.05
Only index persons	47.64	50.88	43.83

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10624	6618	4006
Unadjusted period prevalence (%)	2.07	2.26	1.77
Median age at first event (years)	52.41	52.54	52.19

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9454: Matched controls
94541

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

25.1

323.0

1255

572

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

71.4

323.0

1101

174

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

8.0

323.0

890

1219

M01AB05

ATC

diclofenac; systemic, rectal

2.6

323.0

6803

46593

M76.3

ICD-10 Finland

Iliotibial band syndrome

57.2

323.0

395

M76.7

ICD-10 Finland

Peroneal tendinitis

58.9

323.0

545

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

324.4

323.0

1010

M25.5

ICD-10 Finland

Pain in joint

3.4

323.0

3605

14554

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

99.1

323.0

453

M02AA07

ATC

piroxicam; topical

2.4

323.0

3802

20436

M76.0

ICD-10 Finland

Gluteal tendinitis

64.0

323.0

1276

230

M03BX02

ATC

tizanidine; oral

2.6

323.0

6296

41340

N02AX02

ATC

tramadol; systemic, rectal

3.3

323.0

4410

19862

M79.6

ICD-10 Finland

Pain in limb

3.3

323.0

4195

18251

M54.5

ICD-10 Finland

Low back pain

4.0

323.0

3416

11662

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.9

323.0

5005

26259

M54.4

ICD-10 Finland

Lumbago with sciatica

6.5

323.0

1829

3352

N03AX16

ATC

pregabalin; oral

4.6

323.0

2659

7423

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.8

323.0

2531

10791

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

35.6

323.0

1624

547

M76.5

ICD-10 Finland

Patellar tendinitis

34.7

323.0

609

187

N02AJ06

ATC

codeine and paracetamol; systemic

2.7

323.0

3940

19842

M76.6

ICD-10 Finland

Achilles tendinitis

66.0

323.0

3899

994

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

87.8

323.0

1728

240

M54.9

ICD-10 Finland

Dorsalgia, unspecified

6.1

323.0

1079

1959

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

30.5

323.0

952

346

M48.0

ICD-10 Finland

Spinal stenosis

43.0

323.0

1069

279

M70.6

ICD-10 Finland

Trochanteric bursitis

4.5

323.0

1563

4003

N03AX12

ATC

gabapentin; oral

5.6

323.0

1750

3704

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

76.8

323.0

646

M01AH05

ATC

etoricoxib; oral

3.5

323.0

6699

39048

7267A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of ankle and tarsus[TENDINITIS SEU BURSITIS ACHILLIS]

+∞

320.6

306

M01AC06

ATC

meloxicam; systemic, rectal

2.4

319.7

3812

20624

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.0

310.3

1080

2359

N02BE01

ATC

paracetamol; systemic, rectal

2.8

310.1

8161

65190

M03BC01

ATC

orphenadrine (citrate); systemic

2.8

309.0

2475

10668

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

108.8

307.4

336

L03

ICPC

Low back symptom/complaint

2.9

298.2

2250

9312

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

12.5

295.9

552

467

M01AE02

ATC

naproxen; oral, rectal

2.2

292.2

5639

37830

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

20.5

288.7

441

225

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

10.7

285.5

574

565

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

22.4

279.9

415

193

M54.3

ICD-10 Finland

Sciatica

9.4

272.5

589

662

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

26.8

263.8

371

144

L16

ICPC

Ankle symptom/complaint

3.6

261.0

1319

4059

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

439.4

258.6

258

A02BC05

ATC

esomeprazole; systemic

2.2

253.9

3907

23133

A02BC02

ATC

pantoprazole; systemic

2.1

253.1

5995

42651

M47.82

ICD-10 Finland

Other spondylosis, cervical region

19.6

252.1

391

208

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.7

251.2

2097

9099

M76.4

ICD-10 Finland

Tibial collateral bursitis [Pellegrini-Stieda]

25.0

249.1

357

148

M01AH01

ATC

celecoxib; oral (coxibs)

2.8

248.1

1870

7621

N06AX21

ATC

duloxetine; oral

3.9

246.0

1137

3237

L13

ICPC

Hip symptom/complaint

3.0

243.1

1614

6052

M43.1

ICD-10 Finland

Spondylolisthesis

27.2

231.7

324

123

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

224.5

2644

13650

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

1109.0

222.6

217

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

219.8

3297

18969

H02AB06

ATC

prednisolone; systemic

2.0

216.7

4284

27575

M47.9

ICD-10 Finland

Spondylosis, unspecified

30.9

213.0

288

M01AE03

ATC

ketoprofen; systemic, rectal

2.1

212.5

3518

21028

M54.1

ICD-10 Finland

Radiculopathy

13.8

212.2

377

284

S86.0

ICD-10 Finland

Injury of Achilles tendon

7.2

206.6

529

774

M01AX17

ATC

nimesulide; oral

2.3

205.1

2318

11644

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.5

201.5

1055

3299

J01DB01

ATC

cefalexin; oral

2.1

197.1

7666

62952

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

8.0

194.1

463

608

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

193.3

185

M01AE01

ATC

ibuprofen; systemic, rectal

2.6

189.8

8552

74327

M54.2

ICD-10 Finland

Cervicalgia

5.1

189.6

642

1336

L17

ICPC

Foot/toe symptom/complaint

2.2

186.9

2366

12447

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.9

186.6

1306

4995

R03AC02

ATC

salbutamol; inhalant

1.9

185.8

4825

33659

S18

ICPC

Laceration/cut

1.9

180.4

3707

23679

M79.1

ICD-10 Finland

Myalgia

2.8

179.3

1295

5045

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

178.4

1849

8810

M01AH02

ATC

rofecoxib; oral

2.8

177.0

1271

4930

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.3

175.2

964

3114

N06AA09

ATC

amitriptyline; systemic

3.4

174.5

918

2866

J01AA02

ATC

doxycycline; systemic

2.0

174.3

7247

59038

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

8.7

174.2

392

468

A02BC03

ATC

lansoprazole; oral

2.1

173.0

2574

14440

J01FA10

ATC

azithromycin; systemic

1.8

172.9

5549

41182

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

9.6

170.6

363

393

R51.80

ICD-10 Finland

Headache

2.6

169.0

1388

5822

L15

ICPC

Knee symptom/complaint

2.2

168.8

1990

10058

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.2

166.5

2021

10348

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

417.2

165.0

165

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

164.9

2485

13962

M02AA10

ATC

ketoprofen; topical

2.4

164.8

1605

7377

M03BC51

ATC

orphenadrine, combinations; systemic

2.0

161.1

2631

15240

WX320

NOMESCO Finland

Spinalanesthesy

2.1

160.9

2167

11594

M01AX05

ATC

glucosamine; oral

2.3

158.8

1752

8553

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

322.3

158.4

160

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

32.8

157.2

209

ZXA00

NOMESCO Finland

Right side

2.0

152.6

2438

13945

M54.6

ICD-10 Finland

Pain in thoracic spine

4.1

148.5

615

1561

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

9.4

144.8

310

339

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.5

144.8

1252

5371

L86

ICPC

Back syndrome with radiating pain

5.2

142.8

469

938

ZXA05

NOMESCO Finland

Left side

2.0

142.7

2269

12897

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

141.9

2216

12500

R01AD09

ATC

mometasone; nasal

1.8

141.9

4180

29385

X58

ICD-10 Finland

Exposure to other specified factors

2.4

141.8

1370

6226

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.5

141.2

729

2229

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.2

139.2

785

2565

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

1368.6

137.8

134

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

3.1

136.9

843

2931

B01AB05

ATC

enoxaparin; parenteral

1.9

136.7

2681

16424

9477

FHL

Cleansing or splitting of a tendon or tendon sheath (eg tenosynovectomy, tenolysis)

31.1

135.9

183

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.8

133.9

939

3550

R06.0

ICD-10 Finland

Dyspnoea

2.0

133.3

1988

10971

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

133.2

2028

11285

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.4

132.9

1237

5501

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

14.3

132.4

230

164

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

131.5

1379

6511

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

28.9

130.6

179

A02BC01

ATC

omeprazole; systemic

1.9

130.2

2278

13351

L08

ICPC

Shoulder symptom/complaint

2.1

128.7

1676

8727

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.7

128.6

952

3717

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

128.3

3907

27456

NF1AA

NOMESCO Finland

Hip X-ray examination

3.2

128.2

744

2475

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

128.1

1449

7084

NHL10

NOMESCO Finland

Suture or reinsertion of achilles tendon

8.5

126.2

287

348

M50.3

ICD-10 Finland

Other cervical disc degeneration

20.3

125.4

191

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

124.4

1528

7745

SPAT1153

SPAT

Removal of sutures

1.8

124.2

2689

16928

M76.1

ICD-10 Finland

Psoas tendinitis

71.9

123.8

142

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.5

122.2

1062

4539

J01FA06

ATC

roxithromycin; oral

1.7

122.2

3601

24946

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

121.3

2417

14772

M79.7

ICD-10 Finland

Fibromyalgia

5.7

120.3

362

652

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

4.1

120.2

496

1250

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

120.1

1041

4441

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.1

119.7

701

2346

G44.2

ICD-10 Finland

Tension-type headache

2.4

118.5

1152

5218

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.8

118.4

857

3295

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

118.2

1831

10192

J02AC01

ATC

fluconazole; systemic

1.7

117.7

3679

25842

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.4

114.9

1133

5163

M45

ICD-10 Finland

Ankylosing spondylitis

36.0

114.8

149

R52.2

ICD-10 Finland

Other chronic pain

5.6

114.4

348

635

9211

FHL

Exploration or removal of diskusprolapse

295.5

114.3

116

R52.9

ICD-10 Finland

Pain, unspecified

2.8

113.9

782

2907

J01DA01

ATC

[U] cefalexin; systemic

1.6

113.6

5559

44003

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.0

112.3

697

2422

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.3

112.0

360

701

J01CA04

ATC

amoxicillin; systemic

1.7

112.0

7321

62710

M77.4

ICD-10 Finland

Metatarsalgia

3.3

111.2

614

1966

R06AE07

ATC

cetirizine; oral

1.7

110.5

3906

28241

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

110.1

1992

11708

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

109.8

4549

34308

J01MA02

ATC

ciprofloxacin; systemic

1.7

108.5

3189

21857

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

107.5

4942

38215

L01

ICPC

Neck symptom/complaint

2.3

107.4

1118

5219

UJF32

NOMESCO Finland

Coloscopy

1.8

106.2

2055

12340

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

48.4

105.6

129

R4110

NOMESCO Finland

Physiotherapy

1.8

105.4

2272

14138

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

104.9

6328

52351

M01AB55

ATC

diclofenac, combinations; oral

3.2

103.5

600

1986

R42

ICD-10 Finland

Dizziness and giddiness

2.0

103.3

1639

9151

L28

ICPC

Limited function/disability (L)

2.2

103.3

1129

5390

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

100.6

3399

24086

M77.1

ICD-10 Finland

Lateral epicondylitis

2.7

100.3

754

2953

XA402

NOMESCO Finland

ENMG

6.3

99.8

278

454

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.3

99.7

550

1757

H02AB04

ATC

methylprednisolone; systemic

2.1

99.1

1305

6754

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

99.0

1444

7791

N06AX11

ATC

mirtazapine; oral

1.7

98.9

2602

17163

R01AD12

ATC

fluticasone furoate; nasal

1.7

97.2

2686

17955

R03DC03

ATC

montelukast; oral

2.0

96.1

1434

7796

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

96.1

4271

32367

M54

ICD-10 Finland

Dorsalgia

2.4

95.3

893

3944

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

95.2

3448

24782

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

59.6

95.1

112

N02AA05

ATC

oxycodone; systemic

2.3

95.1

1015

4781

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.8

94.8

645

2374

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

94.6

2804

19086

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

19.2

94.4

146

M43.0

ICD-10 Finland

Spondylolysis

44.7

92.9

115

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.6

92.4

734

2964

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

92.2

1466

8153

M01AH03

ATC

valdecoxib; oral

2.9

91.8

608

2200

A02BA02

ATC

ranitidine; systemic

1.9

91.8

1541

8742

WX110

NOMESCO Finland

Local anesthesy

1.6

91.6

6091

50631

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.7

91.4

683

2661

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.8

91.3

1888

11506

M54.8

ICD-10 Finland

Other dorsalgia

4.6

90.7

334

752

R5599

NOMESCO Finland

Other rehabilitation service

5.6

90.6

275

500

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.2

90.5

522

1720

J01FF01

ATC

clindamycin; systemic

1.7

90.4

2301

14953

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.3

89.5

924

4277

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

137.0

89.1

R01AD08

ATC

fluticasone; nasal

1.7

88.1

2536

17049

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.9

87.7

257

448

Z50.1

ICD-10 Finland

Other physical therapy

3.2

87.6

500

1635

M77.9

ICD-10 Finland

Enthesopathy, unspecified

4.2

87.3

347

842

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

8.6

87.2

195

230

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

5.7

87.0

260

464

NH4AE

NOMESCO Finland

Achilles tendon ultrasound examination

15.3

86.7

146

J01FA09

ATC

clarithromycin; systemic

1.6

85.3

2783

19317

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

4.2

85.3

343

842

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

85.2

936

4454

G47.3

ICD-10 Finland

Sleep apnoea

1.8

85.2

1769

10765

N06AX16

ATC

venlafaxine; oral

2.0

84.9

1172

6152

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

9.0

83.4

182

206

P01AB01

ATC

metronidazole; oral, rectal

1.6

83.3

3374

24710

M23.8

ICD-10 Finland

Other internal derangements of knee

3.6

83.0

405

1176

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

10.2

82.8

168

167

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

82.8

3284

23914

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

82.5

673

2754

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.3

81.9

808

3648

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

25.3

81.2

115

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

81.1

5643

46676

A01

ICPC

Pain general/multiple sites

2.7

81.0

600

2322

S83.2

ICD-10 Finland

Tear of meniscus, current

2.5

80.3

704

2992

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.5

80.1

673

2795

N05CF01

ATC

zopiclone; oral

1.6

79.9

2482

16949

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

79.5

2185

14426

M01AC01

ATC

piroxicam; systemic, rectal

2.0

78.9

1138

6066

L29

ICPC

Musculoskeletal sympt/complt other

2.5

78.7

647

2658

AA1AD

NOMESCO Finland

CT of head and brain

1.8

78.1

1706

10514

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.9

77.8

518

1877

Z01.2

ICD-10 Finland

Dental examination

1.5

77.7

3526

26398

M22.4

ICD-10 Finland

Chondromalacia patellae

3.6

77.1

366

1039

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.2

77.0

904

4423

R03BA05

ATC

fluticasone; inhalant

1.8

76.9

1522

9084

M70.7

ICD-10 Finland

Other bursitis of hip

4.8

76.4

264

557

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

76.0

813

3812

L02

ICPC

Back symptom/complaint

2.4

75.6

695

3028

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.3

74.7

778

3603

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

74.7

802

3767

M01AB08

ATC

etodolac; oral

2.4

74.2

661

2833

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

74.0

1283

7312

UKC02

NOMESCO Finland

Cystoscopy

2.0

73.0

1099

5945

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

73.0

R05

ICPC

Cough

1.7

73.0

1766

11198

SPAT1263

SPAT

Sampling

1.5

72.9

3399

25493

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.5

72.7

591

2410

L14

ICPC

Leg/thigh symptom/complaint

2.5

72.6

606

2506

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

72.6

630

2662

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

248.6

72.4

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

72.0

5012

40933

K30

ICD-10 Finland

Functional dyspepsia

2.1

71.8

849

4161

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.8

71.6

481

1751

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.1

71.6

418

1387

R60.0

ICD-10 Finland

Localized oedema

2.1

70.9

837

4099

R03BA02

ATC

budesonide; inhalant

1.8

70.8

1438

8631

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

70.5

1906

12461

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

70.3

4552

36542

R06AX27

ATC

desloratadine; oral

1.6

69.6

2331

16117

M13.9

ICD-10 Finland

Arthritis, unspecified

2.4

69.4

610

2593

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

683.2

69.1

NHL30

NOMESCO Finland

Suture or reinsertion of tendon of foot

8.1

68.9

159

198

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.8

68.9

312

851

R07.3

ICD-10 Finland

Other chest pain

2.3

68.2

712

3295

R05

ICD-10 Finland

Cough

1.7

68.2

1521

9391

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

68.0

3333

25163

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.5

67.3

557

2292

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.8

67.1

454

1659

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

76.7

67.1

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

67.1

1484

9133

Z71.8

ICD-10 Finland

Other specified counselling

1.6

66.7

1901

12580

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

65.7

1611

10215

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

65.7

718

3391

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

65.6

1269

7483

M01AX01

ATC

nabumetone; oral

3.1

65.4

382

1267

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

65.1

974

5243

H02BX01

ATC

methylprednisolone, combinations; systemic

2.8

65.1

443

1625

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.2

65.0

751

3637

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.2

65.0

366

1184

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

64.6

657

2999

R05FB02

ATC

cough suppressants and expectorants

1.5

64.4

3046

22743

H02AB07

ATC

prednisone; oral

1.8

63.9

1135

6498

WX002

NOMESCO Finland

Sedation and analgesia

1.7

63.7

1552

9815

R53

ICD-10 Finland

Malaise and fatigue

1.7

63.6

1466

9120

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

63.6

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

10.2

63.3

128

127

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

63.1

2417

17193

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

63.1

3744

29288

N06AA10

ATC

nortriptyline; systemic

5.0

62.8

210

428

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

4.1

62.8

255

632

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

62.7

2339

16530

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

62.4

900

4773

WX290

NOMESCO Finland

Other blockade of nerve

1.5

62.0

3770

29593

N04BC05

ATC

pramipexole; oral

2.4

61.7

545

2318

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

61.6

2254

15840

R74

ICPC

Upper respiratory infection acute

1.5

61.3

2303

16284

N03AE01

ATC

clonazepam; systemic

2.7

61.3

455

1758

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

61.1

1122

6490

C07AB07

ATC

bisoprolol; oral

1.5

61.1

3356

25787

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

4.0

60.9

256

655

L12

ICPC

Hand/finger symptom/complaint

1.8

60.5

1105

6376

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

60.3

2328

16559

N06AB04

ATC

citalopram; systemic

1.6

60.0

1662

10875

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.5

60.0

501

2068

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

59.6

669

3196

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.6

59.5

459

1813

N05CF02

ATC

zolpidem; oral

1.7

59.5

1441

9078

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

23.8

59.2

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.9

59.1

920

5016

E0000UV

ATC

1.5

59.1

3193

24409

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.7

58.9

429

1637

K02.1

ICD-10 Finland

Caries of dentine

1.4

58.8

4822

39949

D07AC01

ATC

betamethasone; topical

1.5

58.6

2721

20135

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

2.2

58.6

655

3121

G04BD12

ATC

mirabegron; oral

2.1

58.6

712

3521

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

58.0

976

5472

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

57.8

640

3036

ACC51

NOMESCO Finland

Release of median nerve

2.3

57.7

598

2753

M35.7

ICD-10 Finland

Hypermobility syndrome

6.8

57.6

149

221

R20.2

ICD-10 Finland

Paraesthesia of skin

2.4

57.6

516

2211

N02AC04

ATC

dextropropoxyphene; oral

4.1

57.4

235

587

SPAT1310

SPAT

Counselling related to known health issue

1.5

57.0

2449

17799

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

56.7

775

4018

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.0

56.6

797

4183

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

5.8

56.4

166

292

A03FA02

ATC

cisapride; oral, rectal

2.3

56.3

558

2514

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

56.3

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.6

56.2

448

1800

S80.0

ICD-10 Finland

Contusion of knee

2.3

56.2

548

2447

R21

ICPC

Throat symptom/complaint

1.6

55.6

1529

9957

A02BC04

ATC

rabeprazole; oral

2.1

55.6

695

3475

N05BA04

ATC

oxazepam; oral

1.6

55.5

1863

12773

A07EC01

ATC

sulfasalazine; oral, rectal

2.2

55.4

596

2789

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

55.2

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

55.1

1365

8636

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.4

55.1

483

2047

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

54.8

1016

5879

G54.0

ICD-10 Finland

Brachial plexus disorders

4.5

54.6

200

449

1220

FHL

Arthroscopy

2.8

54.3

367

1340

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.7

54.2

385

1447

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

4.3

53.9

210

501

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.5

53.1

445

1839

Z00.0

ICD-10 Finland

General medical examination

1.7

52.9

1391

8939

M75.2

ICD-10 Finland

Bicipital tendinitis

3.8

52.9

235

632

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

97.3

52.8

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

16.8

52.8

NHK10

NOMESCO Finland

Incision or excision of metatarsal or tarsal bone

6.0

52.7

151

257

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

52.7

531

2410

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

52.3

635

3135

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

52.2

1693

11488

E66.8

ICD-10 Finland

Other obesity

2.4

52.2

466

1990

SPAT1301

SPAT

No procedures

1.5

52.2

2287

16632

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

6.5

52.2

140

219

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

52.2

2045

14511

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

52.1

N01

ICPC

Headache

2.0

52.1

748

3950

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

52.0

1812

12510

R52.1

ICD-10 Finland

Chronic intractable pain

12.1

52.0

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

95.6

51.8

S29

ICPC

Skin symptom/complaint other

1.7

51.7

1242

7777

R02

ICPC

Shortness of breath/dyspnoea

1.9

51.7

822

4507

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

4.3

51.6

198

466

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.7

51.5

232

631

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

51.4

1647

11137

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

51.4

764

4089

J01MA12

ATC

levofloxacin; systemic

1.6

51.3

1349

8661

NH2AA

NOMESCO Finland

Heel X-ray examination

7.8

51.3

121

157

KMAK

NOMESCO Finland

1.4

51.1

4405

36431

7266D

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of knee[TENDINITIS SEU APICITIS PATELLAE]

+∞

51.1

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

51.1

SPAT1211

SPAT

Application of soft bandage

2.0

51.0

688

3545

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

50.9

1063

6380

XQ800

NOMESCO Finland

Prick test

2.1

50.8

640

3207

M53.2

ICD-10 Finland

Spinal instabilities

51.1

50.8

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

50.8

896

5093

M01AB01

ATC

indometacin; systemic, rectal

2.2

50.8

533

2467

SPAT1216

SPAT

Assessment of functional ability

1.8

50.6

974

5696

B01AF01

ATC

rivaroxaban; oral

1.9

50.6

842

4691

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

21.9

50.4

SPAT1229

SPAT

Assessment of need for aid

2.2

50.3

519

2379

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

50.1

432

1813

R06AX22

ATC

ebastine; oral

1.6

49.3

1423

9357

J01EA01

ATC

trimethoprim; systemic

1.5

49.2

1861

13072

WZA90

NOMESCO Finland

Other doctors statement

1.5

49.0

1772

12318

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

48.9

796

4396

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

4.7

48.8

170

363

R03AC03

ATC

terbutaline; inhalant

1.7

48.7

1084

6629

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

48.5

789

4358

M09AX01

ATC

hyaluronic acid; parenteral

2.6

48.4

374

1479

J01DA06

ATC

[U] cefuroxime; systemic

1.7

48.3

1188

7479

N05BA01

ATC

diazepam; systemic, rectal

1.8

48.1

948

5582

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

47.9

1511

10161

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

5.1

47.6

154

304

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

47.4

446

1955

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

47.3

553

2682

N02AJ13

ATC

tramadol and paracetamol; systemic

4.6

46.8

166

362

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

46.7

2000

14418

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

46.5

486

2242

R03BA08

ATC

ciclesonide; inhalant

2.0

46.5

667

3515

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

7.7

46.5

110

144

M77.0

ICD-10 Finland

Medial epicondylitis

3.5

46.4

230

677

R03BA01

ATC

beclometasone; inhalant

1.7

46.4

1065

6567

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

46.3

2183

16047

NFM20

NOMESCO Finland

Excision of bursa of hip or thigh

23.7

46.1

ZXA10

NOMESCO Finland

Bilateral

1.6

45.9

1339

8812

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

160.8

45.8

D19

ICPC

Teeth/gum symptom/complaint

1.5

45.8

2138

15685

C05AA08

ATC

fluocortolone; rectal, topical

1.7

45.7

1102

6889

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.2

45.6

249

788

R35

ICD-10 Finland

Polyuria

2.3

45.6

432

1902

D01

ICPC

Abdominal pain/cramps general

1.9

45.6

766

4275

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

5.2

45.4

145

282

C03CA01

ATC

furosemide; systemic

1.5

45.3

1604

11070

NFL30

NOMESCO Finland

Transposition of muscle of hip or thigh

5.2

45.3

145

283

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

45.3

1289

8432

M01AE52

ATC

naproxen and esomeprazole; oral

2.9

45.2

285

996

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

8.3

45.2

102

124

9476

FHL

Splitting of fascia or aponeurosis

7.3

45.1

111

154

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.1

45.0

532

2594

RF210

NOMESCO Finland

3.2

44.9

246

781

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

44.8

3122

24690

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

44.7

502

2393

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

44.7

445

2008

M24.2

ICD-10 Finland

Disorder of ligament

4.3

44.6

170

398

9473

FHL

Local soft tissue removal or exploration (eg Bursa)

7.1

44.6

111

157

S76.3

ICD-10 Finland

Injury of muscle and tendon of the posterior muscle group at thigh level

4.4

44.5

165

376

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.7

44.5

324

1237

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.9

44.5

687

3720

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

44.4

4157

34537

R06AE09

ATC

levocetirizine; oral

1.6

44.2

1188

7648

M25.2

ICD-10 Finland

Flail joint

5.3

44.2

138

262

NGL58

NOMESCO Finland

Tenolysis or tenosynovectomy of knee or lower leg

71.9

44.0

H01

ICPC

Ear pain/earache

1.8

43.8

782

4453

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.9

43.7

189

497

M19.8

ICD-10 Finland

Other specified arthrosis

2.9

43.7

276

965

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.7

43.6

198

543

M01AC02

ATC

tenoxicam; systemic, rectal

2.4

43.6

393

1685

M76

ICD-10 Finland

Enthesopathies of lower limb, excluding foot

10.1

43.6

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

43.5

3314

26573

SPAT1260

SPAT

Consultation of another employee

1.6

43.5

1273

8381

NF1DA

NOMESCO Finland

X-ray of hips

3.9

43.4

184

476

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

43.4

4153

34584

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

43.4

873

5166

J02AC02

ATC

itraconazole; systemic

1.6

43.3

1464

9984

L84

ICPC

Back syndrome without radiat pain

2.8

43.2

297

1096

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.6

43.1

331

1305

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

43.1

5890

51889

SPAT1312

SPAT

General health counselling

1.4

43.0

2407

18258

M67.4

ICD-10 Finland

Ganglion

2.1

43.0

531

2635

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

42.8

788

4530

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.7

42.7

297

1104

A02BA04

ATC

nizatidine; systemic

2.1

42.5

528

2626

M89.0

ICD-10 Finland

Algoneurodystrophy

7.8

42.5

100

130

D07AC13

ATC

mometasone; topical

1.4

42.4

2273

17089

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.0

42.4

252

847

R96

ICPC

Asthma

2.0

42.4

607

3194

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

42.3

1068

6753

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.1

42.0

476

2278

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.0

42.0

176

451

S06.0

ICD-10 Finland

Concussion

1.9

42.0

710

3969

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

41.9

936

5715

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

41.7

543

2753

C09CA06

ATC

candesartan; oral

1.5

41.6

1641

11579

R51

ICD-10 Finland

Headache

2.3

41.6

389

1702

R03AC13

ATC

formoterol; inhalant

2.3

41.5

385

1678

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

41.4

483

2337

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

3.1

41.4

233

755

G04CA02

ATC

tamsulosin; oral

1.6

41.4

1202

7890

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

41.3

823

4855

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

3.0

41.2

244

819

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.2

41.1

161

388

M66.4

ICD-10 Finland

Spontaneous rupture of other tendons

12.6

41.0

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.7

40.9

286

1067

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

40.6

603

3216

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.8

40.6

267

959

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

40.6

2967

23554

C01CA24

ATC

epinephrine; parenteral

2.1

40.2

506

2530

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.6

40.1

189

535

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

40.1

505

2524

D11

ICPC

Diarrhoea

1.8

40.1

802

4734

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

40.0

1980

14631

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

3.4

40.0

205

620

G04BD08

ATC

solifenacin; oral

2.2

40.0

443

2099

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.2

39.8

419

1939

R13

ICD-10 Finland

Dysphagia

2.2

39.7

429

2009

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.6

39.7

307

1215

J05AB01

ATC

aciclovir; systemic

1.5

39.6

1591

11257

C08CA01

ATC

amlodipine; oral

1.4

39.6

2387

18304

M70.8

ICD-10 Finland

Other soft tissue disorders related to use, overuse and pressure

6.1

39.5

110

182

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

39.4

1237

8266

N06AB10

ATC

escitalopram; oral

1.5

39.4

1505

10530

D01BA02

ATC

terbinafine; oral; topical

1.4

39.3

1922

14158

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

39.2

938

5837

J01FA15

ATC

telithromycin; oral

1.7

39.2

826

4952

C07AA05

ATC

propranolol; systemic

1.5

38.9

1462

10190

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.9

38.7

163

420

K07.60

ICD-10 Finland

Snapping jaw

2.3

38.5

376

1678

P01BA02

ATC

hydroxychloroquine; oral

1.9

38.5

607

3307

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.1

38.5

220

720

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

38.4

572

3054

L18

ICPC

Muscle pain

2.7

38.3

274

1035

NBG10

NOMESCO Finland

Acromioplastia

3.2

38.1

209

665

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

3.2

37.9

207

657

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.0

37.9

230

784

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

37.6

632

3524

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.9

37.5

125

256

NGL30

NOMESCO Finland

Plastic repair or reinsertation of tendon of patella

14.7

37.4

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

37.4

873

5392

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

37.3

2052

15441

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.2

37.2

398

1855

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.6

37.1

173

486

TAB20

NOMESCO Finland

Epidural puncture

9.9

37.0

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

36.9

2555

20025

XF402

NOMESCO Finland

ECG with work load test

1.7

36.9

744

4402

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

36.8

2066

15599

M65.3

ICD-10 Finland

Trigger finger

2.3

36.8

343

1497

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

36.7

524

2753

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

36.7

473

2388

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

36.5

940

5964

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.8

36.5

674

3873

XKD00

NOMESCO Finland

Uroflowmetry

1.7

36.4

907

5705

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

36.2

2996

24158

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

36.0

1107

7349

-1

NOMESCO Finland

1.4

36.0

2641

20879

NH1BG

SPAT

5.7

35.9

105

185

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.7

35.9

164

454

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

35.8

1083

7158

W19

ICD-10 Finland

Unspecified fall

1.8

35.8

642

3654

1221

FHL

Arthroscopy and meniscus surgery

2.9

35.7

228

803

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.6

35.6

276

1091

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

35.6

847

5257

D06

ICPC

Abdominal pain localized other

1.9

35.6

570

3119

M75.8

ICD-10 Finland

Other shoulder lesions

2.7

35.6

254

959

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

35.6

624

3524

J45

ICD-10 Finland

Asthma

1.8

35.6

692

4046

R50.9

ICD-10 Finland

Fever, unspecified

1.6

35.5

968

6231

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

+∞

35.4

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

35.4

3318

27253

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.7

35.3

253

958

C10AA05

ATC

atorvastatin; oral

1.4

35.3

2591

20469

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

35.3

429

2112

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

35.2

702

4135

M41.9

ICD-10 Finland

Scoliosis, unspecified

10.5

35.2

N17

ICPC

Vertigo/dizziness

1.8

35.1

700

4120

L90

ICPC

Osteoarthrosis of knee

2.1

35.1

434

2153

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.1

35.0

197

640

NFL20

NOMESCO Finland

Freeing of muscle of hip or thigh

18.1

34.8

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

34.8

2331

18132

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

6.2

34.6

155

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.1

34.6

413

2021

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

34.5

1423

10095

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

34.4

510

2717

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

3.8

34.3

151

405

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.5

34.3

286

1181

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.4

34.3

315

1366

J20

ICD-10 Finland

Acute bronchitis

1.8

34.2

666

3893

L11

ICPC

Wrist symptom/complaint

1.9

34.1

562

3109

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.5

34.1

270

1081

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

9.9

34.1

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.6

34.1

256

996

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

34.0

746

4519

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.7

34.0

741

4480

A29

ICPC

General symptom/complaint other

1.7

34.0

739

4469

J01CA08

ATC

pivmecillinam; oral

1.3

33.9

3020

24568

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.0

33.7

204

696

J46

ICD-10 Finland

Status asthmaticus

3.0

33.7

203

691

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

33.6

548

3022

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

33.5

393

1907

M20.2

ICD-10 Finland

Hallux rigidus

2.5

33.3

265

1064

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

2.9

33.3

206

714

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.5

33.2

262

1049

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

33.2

887

5674

R06AX13

ATC

loratadine; oral

1.5

33.2

1174

8046

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.3

33.2

310

1353

R09

ICPC

Sinus symptom/complaint

1.8

33.1

553

3072

XF404

NOMESCO Finland

Ambulatory ECG

1.8

32.9

617

3560

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

32.7

868

5541

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.8

32.7

617

3568

R00.2

ICD-10 Finland

Palpitations

1.9

32.7

509

2760

C10AC01

ATC

colestyramine; oral

2.9

32.6

205

715

M77.3

ICD-10 Finland

Calcaneal spur

4.9

32.6

109

225

R11

ICD-10 Finland

Nausea and vomiting

1.9

32.6

510

2771

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

32.5

559

3135

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2566

12403

2.41

293.82

1.4

1.2

7.4

14.8

u/ml

7.30

948

4983

(3013707) Erythrocyte sedimentation rate by Westergren method

7994

60949

2.26

278.51

4.8

3.6

10.8

11.6

mm/h

6.41

7523

56424

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2597

13206

2.28

260.29

1.4

1.2

26.5

38.1

iu/ml

2.31

786

4292

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7845

63668

1.89

172.39

7.7

7.3

75.6

78.0

u/l

6.05

7405

59927

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3419

21979

1.82

164.27

2.2

2.0

175.7

222.5

u/l

2.22

3235

20564

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2825

17175

1.88

162.04

1.9

1.7

1.0

1.2

mg/l

2.05

2156

13064

(3037467) Urinalysis macro (dipstick) panel - Urine

7033

56002

1.76

154.94

4.8

3.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9759

86797

2.53

152.12

16.0

11.8

18.8

23.6

mg/l

47.15

7972

66713

(3013115) Eosinophils [#/volume] in Blood

5591

42272

1.68

144.31

6.3

6.0

0.2

e9/l

0.11

4991

36984

(3037522) Nuclear Ab [Titer] in Serum

1932

10748

1.97

142.47

1.4

1.3

503.8

543.7

titre

0.41

376

2280

(3006315) Basophils [#/volume] in Blood

5423

40778

1.67

142.05

6.1

5.8

0.0

e9/l

0.17

4781

35109

(3001604) Monocytes [#/volume] in Blood

5395

40620

1.67

139.70

6.1

5.8

0.6

e9/l

0.47

4766

34987

(3019198) Lymphocytes [#/volume] in Blood

5524

41941

1.66

137.64

6.2

5.8

2.0

1.9

e9/l

0.86

4935

36795

(3031040) Bacteria [#/volume] in Urine by Automated count

6552

52435

1.65

128.64

5.0

3.8

2420.0

1636.1

e6/l

0.29

702

(3026493) Urate [Moles/volume] in Serum or Plasma

3163

21027

1.72

128.61

2.6

2.5

3155.1

3848.6

umol/l

0.52

2718

18467

(3013826) Glucose [Moles/volume] in Serum or Plasma

5919

46195

1.64

128.37

4.9

4.5

6.5

6.7

mmol/l

12.04

5593

42896

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7887

66324

1.73

127.56

4.4

3.9

14.6

14.7

pmol/l

0.85

7266

60710

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3482

24058

1.67

120.83

2.8

2.5

56.4

58.9

u/l

0.84

3219

22167

(3019069) Monocytes/100 leukocytes in Blood

5116

38902

1.61

120.28

6.5

6.2

8.4

8.6

3.04

4799

36496

(3018010) Neutrophils/100 leukocytes in Blood

5179

39511

1.61

119.98

6.2

5.8

56.1

57.0

6.22

4844

37020

(3013650) Neutrophils [#/volume] in Blood by Automated count

6016

47617

1.61

119.09

8.3

9.4

4.0

e9/l

0.22

5315

41400

(3008898) HLA-B27 [Presence]

618

2272

2.83

118.80

1.1

1.0

—

(3006504) Eosinophils/100 leukocytes in Blood

5086

38692

1.60

118.79

6.2

5.9

2.9

2.8

1.35

4735

36090

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5054

38420

1.60

118.19

6.7

6.6

1.2

mmol/l

2.37

4333

32223

(3002030) Lymphocytes/100 leukocytes in Blood

5235

40160

1.60

117.59

6.3

6.0

29.3

28.3

8.11

4876

37464

(3022096) Basophils/100 leukocytes in Blood

4944

37470

1.60

116.50

6.3

6.0

0.7

0.94

4608

34994

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3929

28202

1.62

115.94

3.7

3.0

31.9

53.3

ng/l

3.87

2495

17714

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9027

79698

1.88

114.94

5.4

4.5

1.9

2.2

mu/l

2.75

8390

73350

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4610

34589

1.59

111.80

6.0

5.9

1.2

mmol/l

1.19

4144

31349

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4905

37698

1.56

104.70

4.0

3.8

—

(40768797) Stomach Pathology biopsy report

1805

10753

1.82

104.44

1.3

1.2

—

(42870588) Differential panel, method unspecified - Blood

3772

27444

1.58

101.55

6.1

5.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5301

41649

1.54

101.12

5.6

6.4

10.5

11.4

umol/l

6.91

5011

39566

(3019550) Sodium [Moles/volume] in Serum or Plasma

9746

89103

2.13

100.82

17.2

13.5

139.8

139.7

mmol/l

2.41

9583

86671

(3023103) Potassium [Moles/volume] in Serum or Plasma

9770

89449

2.15

99.98

17.4

13.6

4.0

mmol/l

4.62

9587

86820

(3032080) INR in Blood by Coagulation assay

4051

30513

1.53

90.46

8.8

8.0

1.2

inr

1.15

1127

8943

(3035350) Ketones [Presence] in Urine by Test strip

4999

39407

1.51

89.65

3.9

3.2

0.0

estimate

1.34

962

7253

(3009261) Glucose [Presence] in Urine by Test strip

5055

40015

1.50

88.35

3.9

3.2

0.0

estimate

0.15

954

7218

(3021601) Nitrite [Presence] in Urine by Test strip

5014

39662

1.50

87.70

5.3

4.4

0.0

estimate

0.45

992

7416

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4118

31333

1.51

86.56

2.1

1.8

99.6

97.0

pmol/l

2.67

2040

16305

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8863

79509

1.69

85.14

6.1

5.2

39.3

mmol/mol

0.07

8279

73861

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4378

33827

1.50

84.95

2.5

2.2

77.5

76.6

nmol/l

1.18

3938

30740

(40761511) CBC panel - Blood by Automated count

9901

92069

2.11

81.76

14.6

11.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1012

5393

1.97

81.34

2.5

2.3

24.3

23.0

au/ml

0.12

408

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6873

58441

1.50

81.09

3.3

2.9

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4328

33682

1.48

79.28

4.8

4.9

36.4

35.7

g/l

12.00

4026

31328

(3015171) Extractable nuclear Ab [Units/volume] in Serum

640

2903

2.28

78.43

1.3

1.2

0.3

1.0

u/ml

2.29

220

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2570

17966

1.57

78.00

1.3

1.9

u/ml

3.07

661

4924

(3048689) Calprotectin [Mass/mass] in Stool

1566

9682

1.72

77.57

2.2

2.3

114.9

132.4

ug/g

1.39

1215

7611

(3030467) Casts [#/volume] in Urine by Automated count

2924

21143

1.53

75.76

3.5

2.9

0.3

0.4

e6/l

4.22

2263

15475

(36304419) Bacteria [Presence] in Urine

2866

20696

1.53

74.48

3.4

2.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9129

83209

1.69

74.44

13.8

11.4

83.2

83.4

ml/min/173m2

0.58

7853

68215

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

925

4924

1.96

74.31

1.4

1.3

48.7

48.1

au/ml

0.02

240

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9246

84579

1.72

74.18

4.9

4.2

5.9

mmol/l

0.30

8570

77740

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2746

19715

1.53

73.05

2.8

928.9

1277.9

ng/l

5.35

2288

16722

(3044889) 12 lead EKG panel

6901

59302

1.47

72.59

3.9

3.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6943

59792

1.47

71.74

3.4

2.9

46.6

46.0

u/l

0.25

6484

56149

(3018095) Leukocytes [#/volume] in Urine

3611

27547

1.47

70.94

4.2

3.4

69.0

100.7

e6/l

2.50

2630

18791

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10038

94461

2.14

70.03

11.5

9.4

27.2

26.8

u/l

1.57

9739

91216

(3002582) Erythrocytes [#/volume] in Urine

3115

23128

1.49

69.92

3.6

3.0

78.9

83.2

e6/l

0.05

2452

17307

(3007164) IgA [Mass/volume] in Serum or Plasma

2254

15912

1.53

63.40

1.5

1.4

2.3

2.4

g/l

1.32

1288

9909

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1168

7015

1.75

63.28

2.1

2.3

359.3

380.6

nmol/l

2.99

1066

6473

(3044640) Blood type and Crossmatch panel - Blood

3291

25147

1.45

62.05

2.4

2.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4442

35877

1.41

61.25

3.2

2.7

109.6

125.9

ug/l

4.77

4128

33474

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1875

12809

1.56

60.90

3.1

2.6

1.0

1.4

e6/l

1.04

1109

7013

(3018418) pH of Serum or Plasma

2996

22560

1.46

60.78

4.2

4.1

7.4

0.23

533

4466

(3013512) EKG study

3014

22759

1.45

60.12

4.1

3.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

386

1572

2.51

60.08

1.7

1.6

6253.0

15493.7

e6/l

6.94

283

1111

(3042936) Bacteria identified in Isolate by Culture

1601

10578

1.60

59.93

2.2

2.0

—

(3007461) Platelets [#/volume] in Blood

10354

99255

2.70

59.76

23.1

17.7

255.3

254.2

e9/l

0.97

10198

96598

(40768804) Tissue Pathology biopsy report

4399

35595

1.40

59.41

2.1

2.0

—

(3035941) MCH [Entitic mass]

10358

99336

2.71

59.28

23.0

17.6

30.3

5.94

10272

97940

(3024731) MCV [Entitic volume]

10359

99354

2.71

59.20

23.0

17.6

91.0

90.8

4.46

10273

97955

(3026361) Erythrocytes [#/volume] in Blood

10359

99366

2.70

58.96

23.1

17.7

4.5

e12/l

0.39

10192

96432

(3010813) Leukocytes [#/volume] in Blood

10360

99383

2.71

58.91

23.1

17.7

6.7

6.6

e9/l

1.46

10192

96423

(3000963) Hemoglobin [Mass/volume] in Blood

10359

99405

2.69

58.19

23.2

17.8

136.8

136.3

g/l

3.62

10278

98015

(3007853) Bacteria identified in Skin by Aerobe culture

1378

8856

1.64

57.56

1.9

1.7

—

(3026008) Bacteria identified in Urine by Culture

2906

21937

1.45

57.54

3.2

2.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2191

15652

1.50

57.46

1.6

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3419

26622

1.42

56.95

3.0

3.6

2.4

mmol/l

0.76

2944

23440

(3005322) IgE [Units/volume] in Serum or Plasma

878

5004

1.82

56.57

1.4

1.3

169.4

253.9

u/ml

2.12

820

4625

(3000850) Epithelial cells [#/volume] in Urine

2167

15507

1.50

56.18

2.8

2.5

5.3

5.9

e6/l

1.54

1934

13482

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9452

88150

1.66

55.98

4.8

4.1

4.7

4.8

mmol/l

4.39

8872

82203

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9559

89452

1.68

55.29

5.2

4.5

2.8

2.9

mmol/l

3.02

8915

82931

(40758558) Short blood count panel - Blood

2757

20760

1.44

54.82

5.9

7.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2016

14296

1.51

54.40

4.1

3.3

211.5

556.2

ng/l

3.70

1435

10654

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2558

19057

1.45

53.65

2.3

2.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9391

87604

1.62

53.56

4.7

4.1

1.5

mmol/l

10.53

8773

81378

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9128

84624

1.56

53.09

4.2

3.7

1.3

mmol/l

9.76

8474

78169

(3021589) Normoblasts [#/volume] in Blood

4538

37451

1.37

51.96

9.7

9.0

0.0

e9/l

0.09

3786

30505

(3011397) Hemoglobin [Presence] in Urine by Test strip

2376

17559

1.45

51.69

3.8

3.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1737

12063

1.53

51.43

3.3

2.7

3.5

2.8

e6/l

1.69

982

6289

(3026782) Osmolality of Urine

2041

14672

1.48

51.10

2.9

2.6

538.2

548.9

mosm/kgh2o

1.30

1763

12449

(3000494) Fungus identified in Specimen by Culture

1413

9399

1.58

50.70

1.5

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

481

2338

2.11

49.29

1.7

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2448

18343

1.43

49.03

2.4

2.2

2.9

mg/l

0.69

2095

15684

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3782

30704

1.36

46.42

4.0

3.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2265

16880

1.43

46.33

1.6

1.5

20.6

20.5

nmol/l

0.04

1918

14501

(3021788) Differential panel - Synovial fluid

302

1252

2.45

45.25

1.6

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1342

9074

1.55

44.37

22.7

21.7

1.3

inr

0.40

180

1396

(3033658) Prothrombin time (PT) actual/Normal

2685

20754

1.39

44.24

4.2

3.8

93.2

92.1

1.54

2620

20254

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1595

11219

1.50

43.75

1.9

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

376

1788

2.14

40.77

1.5

1.4

—

(3025941) Bacteria identified in Stool by Culture

754

4526

1.72

40.21

1.3

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

824

5066

1.68

40.20

1.7

1.6

—

(3022145) Colonoscopy Study observation

1328

9176

1.51

39.38

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3416

27826

1.34

39.22

3.2

31.7

34.7

u/l

1.79

3248

26414

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

457

2372

1.97

39.03

1.4

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

410

2056

2.03

38.60

1.5

1.4

278.0

273.0

ug/g

0.20

233

1171

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1116

7471

1.55

38.25

2.6

2.4

30.9

49.5

u/l

2.12

953

6453

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

422

2146

2.01

38.21

1.2

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2403

18615

1.38

38.08

4.5

4.3

—

(3023368) Bacteria identified in Blood by Culture

2534

19812

1.37

37.86

4.5

4.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

859

5421

1.64

37.78

3.7

4.1

84.5

91.4

ng/l

1.44

752

4711

(3045414) Leukocytes [Presence] in Urine

584

3347

1.79

36.58

2.1

1.8

—

(3019150) Specific gravity of Urine by Refractometry

2103

16044

1.39

36.34

4.3

3.4

1.0

kg/l

0.40

319

2488

(4010399)

860

5481

1.62

36.31

1.4

—

(3044941) Cell count panel - Synovial fluid

243

1020

2.41

35.49

1.5

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1313

9237

1.48

35.39

2.5

2.8

5.8

8.7

umol/l

12.38

1143

8009

(3019309) Folate [Moles/volume] in Red Blood Cells

1736

12885

1.42

35.11

1.8

1.7

1139.5

1147.1

nmol/l

0.13

1312

9712

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

394

2030

1.98

34.37

1.3

9.2

8.7

u/ml

0.05

360

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1096

7483

1.52

34.11

1.8

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

441

2376

1.89

33.69

1.6

1.7

1.2

g/l

0.74

414

2264

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1099

7529

1.51

33.64

1.9

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

429

2294

1.91

33.54

1.6

1.7

0.2

g/l

0.09

402

2179

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

387

2007

1.96

33.14

1.3

4.9

6.9

u/ml

0.28

228

(3013139) Helicobacter pylori Ag [Presence] in Stool

825

5321

1.60

33.06

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

416

2213

1.92

33.03

1.3

18.4

44.1

u/ml

1.48

154

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

574

3373

1.74

32.94

2.1

2.0

39.7

39.2

u/l

0.23

524

3011

(40761535) Cells panel - Urine sediment

842

5479

1.58

32.48

3.9

3.1

—

(3009508) Creatinine [Moles/volume] in Urine

3044

24936

1.31

32.03

3.2

7.8

7.7

mmol/l

0.62

2540

21040

(36660697) Celiac disease serology panel - Serum

957

6443

1.53

31.70

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1279

9135

1.45

31.66

7.1

5.9

—

(3002385) Erythrocyte distribution width [Ratio]

7948

73598

1.32

31.60

18.4

14.9

13.6

1.12

7853

71989

(3029937) Albumin [Presence] in Urine by Test strip

2554

20460

1.33

31.43

4.4

3.5

0.0

estimate

0.47

975

7156

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1800

13693

1.38

31.07

2.7

3.1

2.4

2.5

mmol/l

3.81

1540

12036

(3014765) Yersinia sp identified in Stool by Organism specific culture

395

2128

1.89

30.19

1.2

1.1

—

(3012516) Albumin [Mass/volume] in Urine

2830

23118

1.31

29.99

3.2

3.3

475.3

351.9

mg/l

0.62

1708

14357

(42529406) Shigella sp [Presence] in Stool by Culture

395

2136

1.88

29.84

1.2

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1598

11992

1.39

29.84

2.6

2.5

13.5

13.4

umol/l

0.02

1486

11159

(3019225) pH of Specimen

1093

7656

1.48

29.82

4.0

4.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

8771

82582

1.36

29.73

16.4

13.0

40.3

40.1

1.30

6678

62817

(3017732) Neutrophils [#/volume] in Blood

850

5675

1.54

29.18

2.4

2.8

4.0

4.1

e9/l

0.07

651

4462

(3003327) Ova and parasites identified in Stool by Light microscopy

471

2710

1.77

29.07

1.9

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

385

2112

1.85

27.82

1.2

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

871

5917

1.51

27.53

2.6

2.7

10.2

10.6

g/l

2.71

788

5440

(3000492) Spirometry study

1159

8330

1.44

27.52

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2943

24382

1.29

27.52

3.9

4.0

6.1

9.0

mg/mmol

4.32

1777

15274

(3041096) Erythrocytes [Presence] in Urine by Automated

2736

22460

1.29

27.46

3.5

2.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

655

4189

1.60

27.09

1.1

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

835

5651

1.52

26.85

2.3

2.1

6.6

8.7

ug/l

1.60

707

4976

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1463

11043

1.38

26.07

2.6

2.5

2.4

2.3

g/l

3.45

1356

10237

(3020630) Protein [Mass/volume] in Serum or Plasma

825

5621

1.51

25.67

2.4

2.6

66.5

66.6

g/l

0.08

744

5162

(3004716) Salmonella sp identified in Stool by Organism specific culture

650

4204

1.58

25.62

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

687

4510

1.56

25.37

2.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

335

1811

1.88

25.37

1.3

493.4

500.7

mg/l

0.12

314

1730

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

312

1652

1.92

25.18

1.2

48.0

43.6

u/ml

0.14

179

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1636

12631

1.35

25.16

3.2

3.6

0.8

mmol/l

0.03

1520

11861

(3049717) Cytology report of Urine Cyto stain

422

2454

1.75

25.12

2.4

2.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

312

1656

1.91

25.00

1.2

1.5

4.8

u/ml

1.51

131

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

649

4249

1.56

24.24

3.5

3.4

1.4

1.7

mmol/l

1.72

475

3148

(3009445) Proteinase 3 Ab [Units/volume] in Serum

527

3285

1.64

24.19

1.5

1.6

8.7

16.6

u/ml

1.31

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

184

812

2.29

24.10

1.6

1.5

51.7

57.0

0.89

113

511

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

627

4080

1.57

24.05

1.8

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

259

1313

2.00

23.75

1.9

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

673

4470

1.54

23.56

3.6

3.4

5.1

kpa

0.02

626

4149

(3009343) pH of Capillary blood

666

4414

1.54

23.54

3.6

3.4

7.4

0.01

585

(3017446) Testosterone [Moles/volume] in Serum or Plasma

823

5703

1.48

23.52

2.4

2.1

13.5

12.8

nmol/l

1.04

727

5153

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2713

22610

1.27

23.42

1.7

1.6

1.4

mmol/l

1.32

2283

19062

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

587

3789

1.58

23.31

2.4

2.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

405

2387

1.72

22.99

2.2

2.4

374.7

751.5

ug/l

1.68

372

2254

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

110

389

2.85

22.86

1.1

1.0

10.2

nmol/l

1.45

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

252

1287

1.98

22.64

1.2

1.1

11.9

13.0

au/ml

0.10

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1355

10326

1.36

22.49

4.9

4.2

32.0

32.2

0.16

948

7110

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1102

8122

1.40

22.48

6.9

7.8

5.1

kpa

0.01

1060

7796

(3016502) Oxygen saturation in Arterial blood

992

7180

1.42

22.46

7.1

8.4

96.0

95.8

0.54

964

6933

(3027801) Oxygen [Partial pressure] in Arterial blood

1101

8116

1.40

22.44

6.9

7.8

12.2

12.8

kpa

3.95

1060

7782

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

294

1589

1.87

22.32

1.2

1.3

3.7

3.8

mmol/l

0.77

273

1492

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1348

10279

1.36

22.27

2.7

2.6

22.9

23.2

0.40

1164

8881

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

218

1067

2.06

22.05

1.2

1.3

0.1

0.2

nmol/l

1.65

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

218

1068

2.06

22.00

1.2

1.3

4.4

3.2

nmol/l

0.11

208

1030

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

374

2184

1.74

21.96

2.3

2.1

10.6

11.1

mg/l

0.55

351

2048

(3014051) Protein [Presence] in Urine by Test strip

296

1614

1.86

21.86

2.3

2.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

201

958

2.12

21.82

1.2

1.3

—

(3003396) Base excess in Arterial blood by calculation

1097

8127

1.39

21.67

7.0

7.8

1.1

0.9

mmol/l

0.82

876

6432

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

340

2.90

21.12

1.5

5.1

6.5

u/l

1.69

291

(3025159) Blasts/100 leukocytes in Blood

848

6043

1.44

20.88

4.2

4.3

0.6

0.3

0.25

181

1514

(3004616) Nuclear Ab [Presence] in Serum

197

950

2.09

20.76

1.4

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

447

2784

1.63

20.60

3.9

3.6

24.8

24.9

mmol/l

0.27

410

2584

(3047007) Chlamydophila sp Ab [Presence] in Serum

236

1222

1.95

20.42

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1278

9800

1.35

20.23

6.1

6.2

1.0

mmol/l

0.16

1186

9182

(3017181) Myelocytes/100 leukocytes in Blood

924

6726

1.41

20.19

4.2

0.8

1.0

0.37

218

1903

(3044290) Cell count panel - Cerebral spinal fluid

281

1549

1.84

20.08

1.2

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

287

1595

1.82

19.97

1.9

1.8

207.1

201.2

pmol/l

0.41

271

1524

(3021440) Promyelocytes/100 leukocytes in Blood

887

6425

1.42

19.93

4.2

4.3

0.3

0.1

0.57

205

1786

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

417

2577

1.64

19.83

1.7

1.6

330.7

331.8

titre

0.00

103

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

343

2016

1.72

19.71

2.3

2.1

38.6

37.8

g/l

1.74

299

1739

(3024980) IgG subclass 4 [Mass/volume] in Serum

238

1252

1.92

19.67

1.6

0.6

0.8

g/l

4.02

191

930

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

374

2252

1.68

19.66

1.1

5.3

7.3

u/ml

0.37

331

(3002179) Metamyelocytes/100 leukocytes in Blood

850

6128

1.42

19.60

3.9

4.1

0.7

0.00

170

1398

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

285

1592

1.81

19.51

1.3

1.4

19.3

36.3

e6/l

0.81

216

1178

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2687

22755

1.24

19.49

4.9

4.5

2.9

ug/l

0.01

2439

20540

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

285

1594

1.81

19.43

1.3

1.5

630.9

1300.6

e6/l

0.86

225

1259

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

232

1217

1.93

19.34

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1474

11616

1.31

19.23

2.1

2.2

29.7

29.8

0.32

1431

11279

(3019060) Gas panel - Arterial blood

636

4356

1.49

19.21

5.0

5.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1982

16255

1.27

18.94

1.6

24463955.2

34496643.1

pmol/l

0.38

1631

13587

(3014111) Lactate [Moles/volume] in Serum or Plasma

863

6291

1.40

18.66

6.6

7.7

1.3

mmol/l

0.72

834

6094

(3028026) IgM [Mass/volume] in Serum or Plasma

670

4673

1.46

18.46

1.8

1.9

1.2

1.4

g/l

2.10

599

4278

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

283

1607

1.78

18.36

1.4

—

(3022313) Gas panel - Capillary blood

491

3219

1.55

18.23

3.8

3.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

390

2430

1.63

17.97

2.3

2.2

3.0

3.1

g/l

1.19

313

1928

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

408

2574

1.61

17.87

2.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

130

564

2.32

17.84

1.3

1.1

1.6

u/ml

0.28

243

(3014576) Chloride [Moles/volume] in Serum or Plasma

1194

9226

1.33

17.83

7.1

7.6

104.4

104.6

mmol/l

0.64

1175

9032

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

408

2576

1.61

17.82

2.2

7.2

7.4

g/l

0.69

319

1966

(3022621) pH of Urine by Test strip

705

5000

1.44

17.77

3.0

2.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

407

2570

1.61

17.76

2.2

3.6

3.9

g/l

2.08

307

1871

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

373

2306

1.64

17.74

1.9

1.7

39.6

40.9

nmol/l

0.52

361

2246

(3020961) Endomysium IgA Ab [Titer] in Serum

566

3849

1.50

17.71

1.1

247.5

226.3

titre

—

125

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

510

3415

1.52

17.19

4.6

24.5

24.1

mmol/l

2.25

457

3111

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1180

9157

1.32

17.07

2.2

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

591

4087

1.47

17.01

1.6

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

901

6721

1.37

16.93

7.7

8.7

123.4

121.3

g/l

2.20

880

6483

(3024263) Appearance of Synovial fluid

338

2.68

16.80

1.7

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

383

2420

1.60

16.69

2.2

9.8

10.4

g/l

2.23

326

2048

(3039162) Centromere protein B Ab [Units/volume] in Serum

192

998

1.94

16.52

1.2

1.3

78.8

59.9

u/ml

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

158

771

2.07

16.24

1.1

—

3.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

131

595

2.22

16.18

1.5

1.4

69018.2

108055.8

e6/l

0.38

396

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

350

2191

1.62

15.86

2.5

2.3

0.7

0.8

g/l

0.35

305

1877

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

130

594

2.20

15.83

1.5

28.5

31.1

0.31

355

(40768443) Skin Pathology biopsy report

522

3573

1.48

15.83

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

469

3144

1.51

15.74

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

299

1806

1.67

15.61

2.5

2.2

0.0

g/l

0.00

277

1657

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

302

1829

1.67

15.60

2.5

2.2

0.0

g/l

0.78

278

1659

(3045424) Erythrocytes [Presence] in Urine

232

1308

1.79

15.49

1.7

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

143

687

2.10

15.35

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1129

8835

1.31

15.31

1.5

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

166

846

1.98

15.16

2.0

17.5

26.6

mg/l

2.35

234

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

316

1954

1.64

15.07

2.4

2.2

0.0

g/l

0.11

291

1777

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.61

15.05

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

117

523

2.25

15.05

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1030

7980

1.32

15.00

2.6

1.8

0.10

913

7098

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1055

8206

1.32

14.93

2.1

1.9

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

407

2.42

14.92

1.5

6.5

8.0

ug/l

0.78

357

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1081

8448

1.31

14.78

3.9

4.6

234.9

242.4

u/l

1.21

1010

8019

(3000330) Specific gravity of Urine by Test strip

536

3756

1.45

14.42

3.6

3.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

731

5420

1.37

14.23

3.2

3.4

4.5

pmol/l

0.13

645

4850

(3017143) Hepatitis C virus Ab [Presence] in Serum

1215

9690

1.29

14.23

1.7

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1186

9440

1.29

14.10

1.6

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

855

6518

1.34

13.90

4.8

4.0

5.9

5.8

kpa

0.72

827

6324

(3024928) Oxygen saturation in Venous blood

255

1524

1.69

13.90

4.2

3.7

—

(3002032) Base excess in Venous blood by calculation

851

6501

1.34

13.64

4.8

4.0

2.0

1.8

mmol/l

0.64

714

5300

(4094501)

355

2315

1.55

13.57

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

376

2.41

13.56

1.1

u/l

0.13

165

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

125

602

2.09

13.39

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

201

1136

1.78

13.38

1.6

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

770

5814

1.35

13.34

2.8

2.7

70.8

70.7

e9/l

0.02

595

4310

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

458

3162

1.47

13.33

1.1

73.0

8.2

u/ml

—

(3052851) Hemolysis interference index of Serum or Plasma

350

2286

1.55

13.29

2.8

3.1

—

(3000991) Gas panel - Venous blood

804

6132

1.34

13.02

7.9

9.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

761

5758

1.35

13.01

2.8

2.7

130.8

188.6

ng/l

7.82

686

5224

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

123

598

2.07

12.87

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

123

598

2.07

12.87

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

222

1308

1.71

12.79

1.2

2.4

3.1

u/ml

0.41

469

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

320

2.48

12.76

1.9

2.7

424.4

280.6

ug/l

0.13

305

(3024354) Oxygen [Partial pressure] in Venous blood

703

5272

1.36

12.74

3.8

3.3

4.7

kpa

0.09

676

5093

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

827

6355

1.33

12.72

2.5

71.4

67.6

ml/min/173m2

2.24

352

2402

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

123

601

2.06

12.70

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

123

601

2.06

12.70

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

122

598

2.05

12.50

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

780

5963

1.33

12.43

1.2

122.7

157.9

iu/ml

1.75

272

2305

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

117

566

2.08

12.42

1.2

1.1

44.1

42.1

mg/l

0.10

101

459

(3025577) Chromium [Mass/volume] in Blood

358

2.36

12.16

2.3

2.1

2.0

2.7

ug/l

1.09

292

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2102

18087

1.20

12.10

4.1

3.8

21.6

21.7

0.09

933

8273

(3008152) Bicarbonate [Moles/volume] in Arterial blood

572

4187

1.39

12.06

8.0

7.4

24.9

24.5

mmol/l

2.29

541

3909

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

215

1277

1.70

12.05

1.2

3.9

3.7

u/ml

0.07

572

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

327

2154

1.53

11.99

1.4

1.5

5.9

18.4

iu/ml

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

114

554

2.07

11.98

1.1

271.2

249.6

mg/l

0.48

105

478

(46235355) HIV 1 and 2 tests - Meaningful Use set

1773

15032

1.22

11.90

1.9

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

178

1009

1.78

11.79

1.4

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

546

3982

1.39

11.77

7.5

10.0

24.4

24.2

mmol/l

0.85

510

3758

(3024522) Salmonella sp identified in Specimen by Organism specific culture

176

996

1.78

11.72

1.4

1.5

—

(3011985) Renin [Units/volume] in Plasma

187

1078

1.75

11.69

1.4

1.5

57.8

65.8

mu/l

0.30

169

956

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

441

3109

1.44

11.54

3.7

2.9

0.6

0.7

2.79

421

2997

(3005988) Vibrio sp identified in Specimen by Organism specific culture

173

979

1.78

11.53

1.4

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

368

2.29

11.44

2.2

2.0

2.9

3.6

ug/l

0.51

322

(1002224) Polysomnography panel

552

4053

1.38

11.43

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

210

1258

1.68

11.43

1.1

4.8

3.3

u/ml

0.36

660

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

174

990

1.77

11.39

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

172

976

1.77

11.37

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

172

979

1.77

11.25

1.4

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

142

762

1.88

11.25

1.5

1.3

6.7

7.0

g/l

0.46

103

509

(3024139) IgG subclass 3 [Mass/volume] in Serum

142

762

1.88

11.25

1.5

1.3

0.4

g/l

1.06

104

508

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

216

1310

1.66

11.23

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

142

763

1.87

11.21

1.5

1.3

2.8

3.1

g/l

1.14

102

510

(4062490)

140

753

1.87

11.02

1.5

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

154

855

1.81

10.96

1.2

1.5

—

(3002256) Pathology report gross observation

1364

11364

1.23

10.81

1.3

—

(3036489) Thrombin time

435

3098

1.42

10.78

1.8

2.1

21.7

21.4

0.29

364

2686

(3036071) Salmonella sp Ab [Titer] in Serum

249

2.54

10.77

1.2

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1313

10926

1.23

10.51

1.7

1.4

0.37

1128

9715

(3034891) Synovial lining cells/100 cells in Synovial fluid

313

2.34

10.49

1.4

1.5

4.8

2.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

348

2390

1.47

10.48

1.6

0.0

0.7

iu/ml

1.31

485

(3003338) MCHC [Mass/volume]

7973

76522

1.17

10.44

19.6

15.2

332.9

332.5

g/l

2.75

7941

75973

(3036670) Protein [Mass/volume] in Synovial fluid

190

2.75

10.40

1.6

1.3

35.9

38.5

g/l

0.59

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

172

1004

1.72

10.34

1.3

248.3

313.3

pmol/l

1.19

137

762

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

986

7972

1.26

10.23

3.3

3.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

406

2.15

10.22

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1580

13428

1.21

10.22

3.1

2.8

0.7

0.8

ug/l

3.58

989

8388

(3024891) Influenza virus A+B Ag [Presence] in Specimen

320

2173

1.49

10.21

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

479

2.06

10.21

1.5

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

263

2.44

10.11

1.2

0.3

g/l

0.04

208

(4027681)

428

2.11

10.08

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

205

1263

1.64

10.07

1.1

123.1

116.6

2.05

181

1136

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

233

1484

1.58

9.99

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

233

1484

1.58

9.99

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

478

2.04

9.90

1.5

1.3

—

(4306422)

210

1309

1.62

9.85

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

149

849

1.77

9.78

1.6

1.5

31.0

32.6

iu/ml

—

(3023410) Appearance of Cerebral spinal fluid

137

763

1.81

9.71

1.2

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

559

4229

1.34

9.60

4.4

3.4

130.8

129.3

g/l

0.80

543

4135

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

393

2.12

9.43

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

425

3088

1.39

9.43

2.0

1.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

266

2.38

9.41

1.1

104.1

545.4

ng/l

0.81

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

242

2.45

9.39

1.2

111.1

112.2

0.12

216

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

390

2795

1.41

9.38

1.9

1.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

293

1999

1.48

9.18

4.6

4.4

3.9

mmol/l

0.30

279

1862

(3009214) Lutropin [Units/volume] in Serum or Plasma

325

2266

1.45

9.10

1.4

9.6

11.2

u/l

1.32

255

1840

(3016244) Insulin [Units/volume] in Serum or Plasma

460

2.01

9.06

4.1

3.8

33.7

30.3

mu/l

0.25

436

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

654

5106

1.30

8.99

1.9

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

279

1894

1.49

8.97

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

212

1357

1.57

8.94

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

525

3980

1.34

8.91

1.7

1.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

233

1526

1.54

8.88

1.1

4.4

5.5

u/ml

0.42

123

741

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

252

1679

1.51

8.87

1.1

0.9

1.5

u/ml

1.09

107

621

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

108

584

1.86

8.48

1.8

2.2

18.2

18.3

nmol/l

0.03

101

547

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

111

608

1.83

8.37

1.2

51.6

40.1

u/ml

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

142

840

1.70

8.24

1.6

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

505

3856

1.33

8.18

3.0

2.6

0.2

0.3

e6/l

1.97

482

3728

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

340

2444

1.40

8.09

2.3

2.5

175.0

188.6

2.32

315

2325

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

153

932

1.65

7.96

1.1

99.2

96.3

0.64

140

873

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

916

7558

1.23

7.91

2.4

2.3

0.2

g/l

4.66

864

7073

(3020891) Body temperature

358

2608

1.39

7.88

4.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.42

7.88

1.1

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

824

6726

1.24

7.86

7.8

8.0

9.2

9.4

mmol/l

0.29

792

6429

(3011288) Drugs identified in Urine by Screen method

291

2049

1.43

7.79

3.1

2.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

214

1421

1.52

7.72

1.1

2.4

1.9

u/ml

0.20

326

(44813793)

101

552

1.84

7.71

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

462

1.91

7.61

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

361

2653

1.37

7.55

1.9

2.2

96.2

91.6

3.39

337

2450

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

257

1781

1.45

7.51

1.6

1.7

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

5.18

7.44

1.2

1.0

0.0

0.1

u/ml

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

371

2747

1.36

7.41

2.3

2.0

1.9

2.3

ug/l

0.37

322

2468

(4268621)

145

889

1.64

7.39

2.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

218

1468

1.50

7.37

1.1

1.9

1.3

u/ml

0.28

586

(3013166) Neutrophils/100 leukocytes in Synovial fluid

172

2.51

7.30

1.2

1.4

55.6

54.4

0.07

148

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

792

6492

1.24

7.28

3.3

3.7

1.2

mmol/l

0.03

691

5668

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

106

599

1.78

7.28

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

119

696

1.72

7.25

1.3

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

516

1.83

7.11

1.0

1.1

5.1

7.6

iu/ml

0.82

141

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

200

1336

1.51

7.05

1.5

1.4

30.0

32.2

u/l

0.36

162

1084

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

170

1096

1.56

7.05

1.6

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

103

583

1.77

7.05

1.2

2.1

8.5

u/ml

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

238

2.23

6.98

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

148

926

1.61

6.98

7.3

6.6

11.2

mg/l

0.02

136

861

(3009015) Lactate [Moles/volume] in Synovial fluid

3.49

6.97

1.6

1.2

3.7

6.8

mmol/l

3.40

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

247

1729

1.44

6.88

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

293

2.09

6.80

3.2

1.6

122.3

147.3

umol/l

0.26

137

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

289

2088

1.39

6.75

3.0

3.2

32.3

45.9

mg/l

1.52

238

1673

(3034860) Kappa light chains.free [Mass/volume] in Serum

289

2089

1.39

6.73

3.0

3.2

36.4

55.1

mg/l

4.35

238

1670

(4024509)

117

699

1.68

6.63

1.8

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1710

15132

1.16

6.63

1.5

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

375

2834

1.34

6.59

2.2

4093.3

5468.7

u/l

0.43

123

1118

(44816559) Phosphatidylethanol [Mass/volume] in Blood

216

1487

1.46

6.59

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

282

2038

1.39

6.58

2.9

3.1

3.5

2.4

ratio

0.24

144

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

408

1.89

6.54

1.3

1.6

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

5.21

6.48

1.2

1.0

0.0

0.1

u/ml

—

(3028707) Methadone [Presence] in Urine by Screen method

190

1281

1.49

6.45

3.4

2.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

108

637

1.70

6.43

1.6

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

108

637

1.70

6.43

1.6

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

108

637

1.70

6.43

1.6

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

177

2.38

6.42

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

563

4516

1.26

6.31

1.3

27.9

31.5

iu/l

1.98

503

3891

(3026389) Candida sp identified in Specimen by Organism specific culture

171

1135

1.51

6.27

1.5

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

344

1.95

6.26

2.6

2.1

105.4

164.3

ug/min

0.29

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

448

3499

1.29

6.23

1.7

3.1

3.6

mg/l

0.78

334

2432

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

480

1.80

6.22

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

156

2.44

6.16

1.5

1.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

177

1188

1.50

6.16

1.1

1.5

g/l

0.26

161

1078

(3034426) Prothrombin time (PT)

298

2.02

6.16

1.2

—

(3037121) Protein [Mass/volume] in Urine

346

2614

1.33

6.13

3.1

3.4

0.3

g/l

0.15

139

1151

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

128

800

1.61

6.12

1.7

1.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

172

1151

1.50

6.08

1.0

1.1

4.9

4.1

u/ml

0.18

438

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

304

2256

1.36

6.06

2.0

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

181

1225

1.49

6.06

1.1

3.0

3.6

u/ml

0.30

448

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

187

1277

1.47

5.99

1.6

1.5

—

(3036603) Volume of Urine

538

1.74

5.97

1.8

1.7

1570.5

1973.4

1.61

111

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

131

829

1.59

5.96

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

264

1921

1.38

5.96

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

244

1756

1.40

5.89

2.6

3.0

24.3

24.8

mmol/l

1.32

220

1527

(3021879) Hepatitis B virus core Ab [Presence] in Serum

761

6355

1.21

5.87

1.4

1.5

—

(4146454)

128

810

1.59

5.83

2.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

323

2435

1.34

5.82

2.8

2.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

173

2.32

5.81

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

168

2.33

5.72

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

118

736

1.61

5.72

1.8

1.9

—

(3014271) Vancomycin [Susceptibility]

273

2.02

5.69

3.1

2.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

153

1018

1.51

5.59

1.6

1.5

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

587

1.68

5.58

1.3

1.8

2.1

mmol/l

3.06

553

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1422

12569

1.15

5.56

1.7

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

409

3207

1.29

5.56

1.7

1.5

g/l

0.07

347

2746

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

498

4002

1.26

5.53

9.4

10.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

233

1687

1.39

5.46

2.1

2.2

132.1

130.6

g/l

0.41

172

1189

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.23

5.43

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

314

2387

1.33

5.38

1.3

72.3

146.8

titre

1.75

223

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

358

2772

1.30

5.37

1.3

226.2

229.3

miu/ml

0.05

153

1295

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

173

2.26

5.37

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.74

5.35

1.2

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

215

1542

1.40

5.33

2.4

2.5

16.9

16.5

0.82

121

795

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.18

5.30

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

309

2349

1.32

5.30

1.3

516.7

944.8

titre

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

260

2.00

5.30

1.3

1.4

14.3

15.7

pmol/l

1.07

224

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

143

2.38

5.28

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

345

1.86

5.24

1.2

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

214

1544

1.39

5.14

2.6

3.1

—

(3044927) Protein electrophoresis panel - Urine

100

616

1.63

5.14

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

164

2.26

5.12

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

271

1.96

5.09

1.3

1.2

—

(44806118)

125

815

1.54

5.06

1.5

—

(44790047)

125

815

1.54

5.06

1.5

—

(44790049)

125

815

1.54

5.06

1.5

—

(44790048)

125

815

1.54

5.06

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

512

1.69

5.05

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

512

1.69

5.05

1.2

1.1

ratio

0.17

203

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

402

1.77

4.98

1.1

12.1

8.5

u/ml

0.30

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

108

684

1.58

4.97

2.4

2.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

470

1.71

4.94

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

207

1497

1.39

4.92

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

174

1225

1.43

4.83

1.8

2.1

2.2

8.5

titre

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

236

2.00

4.77

1.4

1.3

—

(3016879) Cocaine [Presence] in Urine

379

3007

1.27

4.74

2.7

2.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

184

2.12

4.67

1.5

1.3

—

(3028300) Cannabinoids [Presence] in Urine

410

3291

1.26

4.66

2.6

1.9

—

(3027008) Opiates [Presence] in Urine

409

3284

1.26

4.64

2.5

1.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

140

954

1.47

4.63

1.7

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

205

1499

1.37

4.59

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

568

1.61

4.49

2.8

2.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

174

2.13

4.48

1.4

1.3

102.8

122.9

nmol/l

0.67

123

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

306

2382

1.29

4.48

2.8

2.6

—

(3000764) Benzodiazepines [Presence] in Urine

404

3255

1.25

4.46

2.6

1.9

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

380

1.74

4.42

1.1

93.6

94.5

0.08

303

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

179

1289

1.40

4.41

1.7

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

101

650

1.56

4.39

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

181

1308

1.39

4.37

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

112

2.41

4.37

1.3

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

360

1.75

4.34

1.7

2.2

18.0

24.5

umol/l

—

(3029075) Extractable nuclear Ab panel - Serum

238

1.94

4.32

1.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

144

2.23

4.32

1.3

1.2

56.5

39.7

1.35

105

(3023419) Bacteria identified in Sputum by Culture

126

857

1.48

4.25

3.0

2.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

100

648

1.55

4.23

1.1

289.4

290.6

mg/l

0.05

577

(3033923) Metanephrine [Moles/time] in 24 hour Urine

127

2.29

4.18

1.0

1.2

0.6

0.7

umol/24h

0.21

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

103

679

1.52

4.05

1.3

1.2

261.9

221.4

titre

0.15

122

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

231

1760

1.32

4.00

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

145

1026

1.42

3.99

1.0

0.4

0.7

u/ml

0.39

197

(40762814) Titanium [Mass/volume] in Blood

105

2.38

3.97

2.5

2.3

4.1

ug/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

653

1.52

3.90

2.0

2.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

132

923

1.44

3.89

1.3

1.2

57.3

62.0

u/l

0.31

609

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

356

2876

1.25

3.89

6.4

5.3

1.7

0.43

341

2702

(40760888) Immunoglobulin light chains.free panel - Serum

211

1595

1.33

3.88

2.6

3.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

390

1.67

3.81

2.3

1.8

133.3

144.1

0.57

367

(4034850)

308

2458

1.26

3.76

10.3

7.9

—

(3021901) Oxygen saturation in Capillary blood

175

1293

1.36

3.75

2.5

2.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

139

989

1.41

3.74

1.6

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

369

3008

1.23

3.73

4.4

3.8

49.7

48.0

0.68

364

2970

(3030313) Adrenal Ab [Titer] in Serum

2.91

3.73

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

244

1.85

3.73

1.1

1.2

1.6

26.1

—

(3011648) Oxygen content in Venous blood

604

1.53

3.72

5.3

2.9

11.4

11.3

0.11

604

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.00

3.68

1.6

0.8

2.4

mg/l

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

352

2861

1.24

3.66

1.6

1.7

292.9

311.1

mu/l

0.33

322

2577

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

519

1.57

3.66

1.3

1.2

81.9

90.3

u/l

0.37

447

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.11

3.64

1.7

47.8

43.2

umol/l

0.38

(3027944) Amphetamines [Presence] in Urine

393

3242

1.22

3.56

2.2

1.9

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.33

3.49

1.5

1.2

58.2

59.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

416

1.61

3.47

1.5

2.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

416

1.61

3.47

1.5

2.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

416

1.61

3.47

1.5

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

416

1.61

3.47

1.5

2.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

324

2629

1.24

3.45

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

108

746

1.45

3.44

1.3

—

(3002619) Bacteria identified in Specimen by Culture

152

2.04

3.44

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

210

1619

1.30

3.40

1.5

119.3

113.9

u/ml

0.19

358

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

163

1212

1.35

3.40

1.3

7.1

7.2

mmol/l

0.15

126

888

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

506

1.55

3.37

1.3

1.2

20.6

23.3

u/l

0.26

425

(3035637) Corticotropin [Mass/volume] in Plasma

131

942

1.40

3.36

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

128

917

1.40

3.35

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

344

2819

1.23

3.35

6.6

5.4

0.9

0.36

329

2650

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

168

1261

1.34

3.30

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

205

1.86

3.24

1.0

1.1

1.0

1.7

u/ml

0.45

108

(3047181) Lactate [Moles/volume] in Blood

272

2184

1.25

3.21

7.0

6.2

1.3

mmol/l

0.95

244

1926

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

208

1.83

3.11

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

202

1572

1.29

3.09

2.5

3.0

8.5

8.3

kpa

1.31

191

1446

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

127

923

1.38

3.09

2.8

3.5

5.6

11.9

nmol/l

0.51

122

901

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

461

1.54

3.09

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

135

992

1.37

3.07

1.5

—

(3037756) Immunofixation for Serum or Plasma

180

1382

1.31

3.05

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

146

1.99

3.04

1.9

1.7

85.0

125.9

ng/l

1.25

146

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

106

2.17

3.02

1.1

0.0

0.1

u/ml

0.87

(4015189)

182

1.87

2.99

3.7

1.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

100

2.20

2.98

1.7

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

322

2658

1.22

2.96

1.4

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

670

1.44

2.96

4.1

3.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

225

1787

1.26

2.94

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

176

1.88

2.94

1.1

1.2

319.3

347.7

pmol/l

0.15

131

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

131

967

1.36

2.92

1.0

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

163

1.90

2.88

1.9

1.6

0.3

0.4

ug/l

2.39

105

(3020876) Protein [Mass/time] in 24 hour Urine

599

1.46

2.88

1.7

2.0

0.2

1.3

g/24h

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

122

893

1.37

2.87

1.7

2.2

5.8

8.5

umol/l

1.24

661

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.93

2.85

1.1

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.29

2.83

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

193

1.82

2.83

1.6

1.3

16.8

17.0

umol/l

0.11

170

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

215

1.77

2.82

1.6

9.3

8.4

ug/l

1.29

215

(40761536) Microorganisms panel - Urine sediment

794

7082

1.13

2.78

4.3

3.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

152

1158

1.32

2.76

1.7

1.8

1.7

mmol/l

0.48

147

1130

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

378

1.56

2.76

1.9

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

572

1.45

2.76

2.8

2.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

131

1.99

2.74

1.5

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

278

1.66

2.72

2.4

2.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

201

1592

1.27

2.72

2.7

2.9

34.5

35.1

umol/l

0.14

168

1386

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

357

3004

1.19

2.72

1.5

—

(4198724)

348

1.58

2.71

1.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

460

1.50

2.70

1.6

1.5

42.3

21.1

u/ml

—

100

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

380

0.47

2.70

1.7

2.4

118.8

157.4

nmol/l

1.15

332

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

211

1685

1.26

2.67

2.0

0.9

0.8

nmol/l

0.58

185

1413

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

234

1.71

2.67

1.4

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

297

2461

1.21

2.67

2.4

2.6

3.5

3.6

g/l

0.44

283

2339

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

168

1.85

2.66

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

106

2.08

2.62

1.3

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

289

1.63

2.61

2.5

2.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

289

1.63

2.61

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

328

1.59

2.61

1.6

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

328

1.59

2.61

1.6

2.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

424

1.51

2.60

1.2

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.67

2.59

1.0

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

329

1.58

2.58

1.1

1.0

—

(3006270) Folate [Moles/volume] in Blood

640

1.41

2.55

1.1

367.6

381.7

nmol/l

0.29

548

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

7.14

2.55

1.6

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

174

1367

1.28

2.54

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

293

2442

1.21

2.50

3.5

3.1

0.3

0.4

u/ml

0.35

166

1385

(3003181) Sodium [Moles/volume] in Urine

153

1185

1.30

2.50

1.3

1.4

62.7

63.3

mmol/l

0.06

126

925

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

332

1.57

2.50

1.7

2.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

115

2.00

2.50

1.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

270

1.63

2.48

1.0

1.1

—

(3039000) Anion gap in Blood

192

1533

1.26

2.46

8.3

7.5

11.3

11.4

mmol/l

0.08

180

1383

(3018572) Chloride [Moles/volume] in Blood

192

1534

1.26

2.45

8.3

7.5

104.0

105.2

mmol/l

2.55

180

1384

(3016038) Potassium [Moles/volume] in Urine

430

1.49

2.45

1.1

1.2

31.8

36.0

mmol/l

0.93

374

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

137

1.90

2.45

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

123

1.95

2.44

1.0

2.9

4.9

u/ml

0.16

(3016650) Hepatitis A virus Ab [Presence] in Serum

175

1385

1.27

2.42

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

351

1.54

2.41

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

351

1.54

2.41

1.3

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

124

1.94

2.39

1.6

1.7

—

(3042631) Mycobacterium sp identified in Specimen

132

1009

1.31

2.39

2.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.35

2.38

1.0

1.2

1.7

umol/24h

0.07

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.35

2.38

1.0

0.0

0.9

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

204

1648

1.24

2.38

1.3

270.1

274.9

u/ml

0.06

134

1070

(3012989) Citrate [Moles/time] in 24 hour Urine

6.25

2.37

1.4

1.8

2.3

1.9

mmol/24h

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

218

1779

1.23

2.32

5.4

6.1

4371.7

1707.2

iu/ml

0.31

275

(3008295) Osmolality of Serum or Plasma

101

746

1.36

2.32

1.3

1.5

278.6

280.3

mosm/kgh2o

0.34

594

(3045716) Anion gap in Serum or Plasma

292

1.58

2.29

5.2

2.6

8.5

9.3

mmol/l

0.74

220

(3000093) Morphology [Interpretation] in Blood Narrative

688

1.37

2.29

1.2

1.1

—

(3011412) CD3 cells [#/volume] in Blood

105

783

1.34

2.27

2.7

2.5

1.2

e9/l

0.31

480

(3013466) aPTT in Blood by Coagulation assay

2.68

2.27

1.1

34.5

38.6

1.42

(3012920) Ethanol [Mass/volume] in Serum or Plasma

4.62

2.27

1.0

1.5

—

(3003694) ABO and Rh group [Type] in Blood

2551

24248

1.07

2.24

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

456

1.45

2.23

1.3

5.6

5.8

mmol/l

0.63

433

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

531

1.42

2.22

2.9

2.8

0.3

0.2

e9/l

0.53

467

(3038177) Helicobacter pylori Ab [Presence] in Serum

184

1483

1.24

2.21

1.3

1.2

—

(3036180) Methadone [Presence] in Urine

5.56

2.21

1.8

3.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

100

2.00

2.20

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

524

1.42

2.20

1.1

1.0

0.3

2.2

u/ml

1.40

129

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

107

805

1.33

2.20

1.3

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

617

1.38

2.19

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.34

2.18

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

442

1.45

2.17

1.4

1.5

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.24

2.17

2.3

1.9

1.3

1.4

umol/l

0.08

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

158

1.77

2.16

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

151

1.79

2.15

1.4

1.3

239.7

88.0

mg/l

0.36

118

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

213

1751

1.22

2.14

1.2

—

(3012501) Base excess in Blood by calculation

207

1697

1.22

2.14

3.8

2.5

2.6

mmol/l

0.23

149

1150

(3027273) Bicarbonate [Moles/volume] in Venous blood

380

3289

1.16

2.13

4.6

3.3

25.5

25.2

mmol/l

1.27

368

3198

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

126

1615

0.78

2.12

1.4

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

205

1.66

2.10

3.6

2.2

486.0

597.3

e6/l

0.09

106

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

102

1.96

2.09

1.3

1.1

—

(4281824)

1123

0.74

2.07

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

229

1.62

2.07

1.6

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

148

1174

1.26

2.07

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

110

1.91

2.05

1.1

—

(1616796) Gas panel - Central venous blood

202

1661

1.22

2.04

3.7

3.6

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.22

2.00

1.0

0.3

1.1

u/ml

—

(3010421) pH of Blood

234

1960

1.20

1.97

3.7

3.8

7.4

0.49

205

1658

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.28

1.97

1.9

2.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

621

1.36

1.97

2.7

2.0

13.4

14.2

0.25

271

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

452

1.42

1.96

1.4

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

123

962

1.28

1.95

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

573

1.36

1.91

1.5

1.4

65.6

70.7

umol/l

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

290

1.52

1.91

1.5

1.9

2050.0

13131.6

u/ml

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

109

842

1.30

1.90

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.00

1.89

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

167

1359

1.23

1.89

1.1

9.8

1717.9

iu/ml

1.09

306

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

113

1444

0.78

1.89

1.7

1.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

721

1.32

1.88

1.3

1.5

1.4

nmol/l

0.34

637

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

259

1.55

1.88

1.1

1.2

98.8

86.1

0.97

126

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

575

1.36

1.88

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

1.87

0.0

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

212

1.61

1.87

1.2

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

296

3435

0.86

1.87

1.5

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.39

1.85

1.0

1.1

—

3.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

100

1.90

1.85

1.1

1.3

—

(4035726)

734

8035

0.91

1.81

1.3

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

579

1.35

1.81

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

151

1223

1.24

1.80

1.4

1.2

13.9

29.9

u/l

4.89

128

1054

(3027035) Albumin [Mass/time] in 24 hour Urine

2.06

1.80

1.3

1.4

—

177.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.96

1.79

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

111

869

1.28

1.77

2.9

3.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

165

1355

1.22

1.74

1.5

1.4

0.4

nmol/l

0.13

115

1041

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

489

1.37

1.74

1.2

1.5

—

(3015183) Erythrocyte sedimentation rate

465

1.38

1.71

1.3

1.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

118

1.78

1.69

1.5

2.1

1.2

mmol/l

1.72

113

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.00

1.69

1.3

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

355

3120

1.14

1.68

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

126

1.75

1.67

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

149

1.68

1.66

1.2

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.16

1.66

1.0

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

545

1.34

1.66

2.9

2.7

636.5

517.1

e6/l

0.47

468

(3004809) Band form neutrophils/100 leukocytes in Blood

158

1300

1.22

1.65

2.8

3.3

1.5

1.4

0.05

123

1022

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.03

1.64

1.9

—

(3020491) Glucose [Moles/volume] in Blood

616

1.32

1.63

1.9

6.6

mmol/l

0.01

429

(3020191) Ethanol [Moles/volume] in Serum or Plasma

616

1.32

1.63

1.6

1.3

1.5

1.2

promille

0.85

470

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

269

1.49

1.62

1.1

93.6

86.3

0.88

131

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

181

1.60

1.62

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

181

1.60

1.62

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

181

1.60

1.62

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

181

1.60

1.62

1.1

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

191

1605

1.19

1.61

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

353

1.42

1.59

1.6

1.5

11.0

nmol/l

0.80

298

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.00

1.59

1.0

0.0

0.8

u/ml

—

(3007463) Buprenorphine [Presence] in Urine

2.69

1.58

13.3

7.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

175

1.60

1.57

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

153

1.64

1.52

1.8

1.3

—

(21494755) Public health laboratory ask at order entry panel

997

10679

0.93

1.52

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

274

1.46

1.50

1.5

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.86

1.50

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

223

1913

1.17

1.50

4.5

3.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

249

2156

1.16

1.49

1.8

1.9

39.9

5.0

iu/l

0.47

831

(3037692) Legionella sp identified in Specimen by Organism specific culture

267

1.46

1.48

1.2

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

309

1.43

1.46

4.7

6.3

4970.4

1249.7

mg/l

0.34

221

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.22

1.46

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.37

1.45

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

216

1855

1.17

1.45

2.4

128.3

97.8

ug/min

0.35

133

1156

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.73

1.43

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

102

816

1.25

1.43

2.0

8.2

7.1

7.7

mmol/l

0.61

684

(3042111) Morphology [Interpretation] in Bone marrow Narrative

147

1223

1.20

1.42

1.5

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

345

1.39

1.41

1.3

1.1

—

(3000012) Reticulocyte production index

414

1.35

1.40

1.4

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

466

1.33

1.39

1.9

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

264

1.44

1.36

3.0

3.4

8.4

8.3

mg/l

0.03

213

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

420

0.67

1.36

1.5

1.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.83

1.35

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

734

1.26

1.33

2.3

43.9

39.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

175

1.54

1.33

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.14

1.33

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

803

7474

1.08

1.33

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

161

1362

1.18

1.32

2.6

2.8

546.6

2261.6

u/ml

1.37

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

0.00

1.31

0.0

1.1

—

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

799

1.24

1.31

2.5

3.3

61.1

57.4

0.73

529

(3020393) Adenovirus Ag [Presence] in Stool

1.89

1.28

1.5

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

161

1.55

1.28

1.1

1.3

79.2

67.0

mu/l

0.12

127

(3017704) Immunofixation for Urine

344

1.37

1.27

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

562

1.28

1.26

1.2

—

(3017569) Oxygen content in Arterial blood

328

1.37

1.25

3.0

2.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

107

1.68

1.25

1.3

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

117

0.43

1.24

1.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

346

1.36

1.23

2.3

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

178

1538

1.16

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

169

1957

0.86

1.15

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

657

0.76

1.15

1.1

1.2

—

(3004451) EKG impression Narrative

308

1.37

1.15

1.4

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

535

1.27

1.14

1.0

0.5

1.5

u/ml

1.14

111

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

334

1.35

1.14

2.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

422

1.30

1.12

1.5

1.7

1.0

1.3

nmol/l

1.54

332

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

103

1.65

1.12

1.2

—

(40768795) Lymph node Pathology biopsy report

944

0.80

1.12

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

788

0.79

1.11

1.1

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

493

1.28

1.11

1.0

276.0

407.8

ng/l

1.06

373

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

379

1.32

1.11

1.6

1.5

—

1158307.0

iu/ml

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

414

1.31

1.11

1.9

1.5

—

(40758292) HTLV I+II Ab panel - Serum

143

1.54

1.11

1.1

1.4

—

(3022689) Creatine [Moles/volume] in Urine

234

1.41

1.10

1.4

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

209

1.44

1.10

1.9

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

415

1.30

1.09

1.9

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

424

1.30

1.09

1.5

1.7

1.6

3.0

u/field

1.16

308

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.38

1.09

6.6

6.7

0.4

0.2

mmol/l

—

(44806071)

112

1.61

1.08

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

576

1.25

1.07

1.9

1.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

496

1.27

1.07

1.0

876.3

709.7

ng/l

2.01

363

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.87

1.07

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

103

1233

0.83

1.07

1.3

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.92

1.06

1.1

1.2

—

(3016750) Collection duration of Urine

453

1.28

1.05

2.2

510.6

499.2

min

0.44

360

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.71

1.05

1.9

2.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

498

1.27

1.04

1.0

33.0

43.5

ng/l

1.41

374

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

531

0.75

1.02

1.6

7.8

mmol/l

0.02

325

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.88

1.00

1.3

1.5

279.4

350.3

umol/24h

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

555

1.24

1.00

1.6

1.5

6.9

5.4

u/l

0.29

253

(3046861) Legionella sp Ag [Presence] in Urine

2.00

1.00

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

265

1.36

0.99

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

231

1.39

0.99

1.1

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.71

0.98

1.0

0.0

u/ml

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.71

0.98

1.0

0.0

0.2

u/ml

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

223

1.39

0.98

1.1

63.7

60.5

u/ml

0.08

214

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

432

1.27

0.97

3.6

6.5

511.4

6872.6

u/ml

—

(3012898) Urea [Moles/volume] in Urine

1.67

0.97

1.6

1.5

238.2

163.5

mmol/l

0.89

(3050129) First trimester maternal screen panel - Serum or Plasma

200

2255

0.88

0.97

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.80

0.96

5.9

4.4

—

(3025315) Body weight

1.69

0.95

5.2

4.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.69

0.95

1.0

0.0

0.1

u/ml

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

461

1.26

0.94

1.2

1.1

30.0

26.0

u/l

0.15

356

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

515

1.24

0.94

1.2

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.89

0.94

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

907

9560

0.94

0.93

1.8

1.7

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.22

0.93

1.2

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

183

1.42

0.93

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

103

871

1.18

0.93

4.8

5.1

136.8

80.5

u/ml

0.44

259

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

463

1.25

0.92

1.2

1.1

102.2

88.4

u/l

0.35

368

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

101

854

1.18

0.91

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

118

1.53

0.90

11.6

9.4

5.1

5.4

mmol/l

0.16

118

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

270

1.33

0.90

1.8

1.9

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.07

0.89

2.0

1.2

257.0

542.4

nmol/l

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

492

1.24

0.89

1.0

0.2

1.7

u/ml

0.59

(3044242) Glucose [Moles/volume] in Arterial blood

350

1.29

0.88

4.1

2.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.65

0.87

1.0

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.79

0.87

1.2

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.61

0.87

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.00

0.87

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

182

1617

1.13

0.86

1.7

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

576

1.22

0.86

1.8

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

134

1535

0.87

0.86

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

130

1492

0.87

0.85

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

470

0.77

0.85

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

187

1.39

0.84

1.1

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

587

1.21

0.83

2.4

2.8

933.1

666.0

e6/l

1.66

245

(3048879) Bone marrow aspiration report

196

1.38

0.83

1.7

2.3

—

(40768806) Pleura Pathology biopsy report

800

0.82

0.83

1.8

1.5

—

(3019977) pH of Arterial blood

407

1.25

0.83

4.0

2.4

7.4

1.01

149

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.70

0.80

1.0

—

(3005033) Fetal Nuchal fold Thickness US

130

1483

0.88

0.80

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

276

1.31

0.80

2.6

2.9

29.3

28.9

umol/l

0.07

205

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

464

1.23

0.79

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

233

1.33

0.79

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.67

0.78

1.0

1.1

9.0

8.1

mmol/l

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

162

1819

0.89

0.78

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

163

1829

0.89

0.78

1.4

—

(3019174) dRVVT (LA screen)

1.62

0.78

1.1

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

181

1621

1.12

0.77

2.9

3.7

377.9

700.2

u/ml

0.60

165

1490

(3008037) Lactate [Moles/volume] in Venous blood

178

1593

1.12

0.77

3.5

2.8

1.4

1.6

mmol/l

2.55

172

1553

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

242

2202

1.10

0.77

1.3

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

163

1827

0.89

0.77

1.4

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

0.00

0.76

0.0

1.0

—

1.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.70

0.75

1.1

1.0

—

(40768446) Kidney Pathology biopsy report

359

1.25

0.75

1.8

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

678

1.18

0.75

1.5

1.3

365.4

66.0

pmol/l

0.54

210

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.08

0.74

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.08

0.74

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

163

1822

0.89

0.74

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

100

864

1.16

0.74

2.7

2.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

716

1.17

0.74

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.64

0.73

1.1

6.7

14.0

u/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

117

1.45

0.71

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

362

1.24

0.71

1.1

184.2

178.4

iu/ml

0.05

357

(3001729) Color of Synovial fluid

1.58

0.71

1.0

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

784

0.84

0.71

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.92

0.70

1.0

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

129

1142

1.13

0.69

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.51

0.69

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

152

1.38

0.69

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.53

0.68

1.8

2.5

0.5

0.6

u/field

0.14

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.85

0.68

2.4

3.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

251

2307

1.09

0.67

3.5

3.3

1.4

1.5

mg/l

0.52

230

2133

(3012441) Differential panel - Pleural fluid

758

0.84

0.67

1.7

1.4

—

(3042733) HLA Ab [Presence] in Serum

320

1.25

0.67

6.4

4.8

—

(3038515) Glucose [Moles/volume] in Venous blood

167

1506

1.11

0.66

3.6

2.9

7.1

7.6

mmol/l

2.16

161

1474

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

111

1.44

0.65

1.3

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.54

0.65

2.0

2.5

—

(3045788) Cell count panel - Pleural fluid

647

0.83

0.65

1.8

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.59

0.65

1.6

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

588

5584

1.06

0.64

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

460

0.80

0.64

1.4

1.5

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

128

0.62

0.63

1.5

2.9

34.6

70.4

pmol/l

—

113

(40765096) Chromosome analysis panel by Banding

234

1.28

0.62

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.63

0.62

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

836

0.86

0.61

1.6

1.5

3324.6

2017.5

e6/l

0.28

593

(3027456) Digoxin [Moles/volume] in Serum or Plasma

132

1183

1.12

0.60

2.8

3.1

0.8

nmol/l

0.08

105

900

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

608

6377

0.95

0.59

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

520

0.83

0.59

3.0

3.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.51

0.58

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

140

1.36

0.58

1.5

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

838

1.13

0.57

3.0

3.3

—

(3051593) INR in Capillary blood by Coagulation assay

310

1.23

0.56

2.4

10.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

150

1.33

0.55

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

150

1.33

0.55

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

150

1.33

0.55

1.2

—

(3006462) Nitrate [Presence] in Urine

375

1.20

0.55

4.0

3.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

412

1.19

0.55

28.8

27.7

108.3

116.4

ug/l

0.44

340

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.58

0.54

1.0

1.1

—

(40758358) Immune stain study

1.58

0.54

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

125

1.36

0.53

1.4

1.3

204.1

72.2

ng/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.54

0.53

1.0

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.43

0.52

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

341

1.20

0.52

1.8

2.0

—

(3009871) Measles virus Ab [Titer] in Serum

342

1.20

0.51

1.8

1.7

—

(4211845)

407

1.18

0.50

3.9

2.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

127

1.34

0.49

1.6

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

190

0.74

0.49

2.5

3.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

180

1664

1.08

0.48

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

1.45

0.48

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

883

8540

1.04

0.48

3.3

4.3

14.4

28.1

ug/l

0.76

693

6781

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

189

0.74

0.48

5.0

6.4

—

(3004775) Volume in Urine collected for unspecified duration

625

1.14

0.47

2.5

2.3

657.5

661.8

0.03

448

(3052592) Norovirus Ag [Presence] in Stool

137

1.31

0.47

1.4

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.46

0.46

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

254

0.79

0.45

1.1

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

153

0.72

0.45

3.1

2.3

8.1

7.8

mmol/l

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.40

0.45

1.4

2.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

156

1.28

0.45

4.2

5.4

—

(3044007) Cell count panel - Peritoneal fluid

241

0.79

0.43

2.3

1.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

340

1.18

0.42

3.6

4.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.40

0.42

1.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.41

0.0

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

530

0.87

0.40

1.2

1.3

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.40

0.0

1.2

—

(3047189) Immunofixation for 24 hour Urine

305

1.18

0.40

1.8

2.1

—

(3025130) Human papilloma virus identified in Specimen

142

1314

1.08

0.40

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

751

0.89

0.40

1.6

1.4

14088.3

48988.1

e6/l

2.91

426

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.43

0.39

1.2

1.6

2.0

1.8

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.39

0.0

5.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

353

1.16

0.39

1.4

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

353

1.16

0.39

1.4

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.38

0.38

1.8

2.2

—

(3033799) Differential panel - Peritoneal fluid

280

0.82

0.38

1.9

1.8

—

(3001556) Androgen free Index in Serum or Plasma

1.30

0.37

1.0

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

114

0.70

0.37

2.9

3.7

—

(3042517) Benzodiazepines panel - Urine

1.39

0.36

3.1

2.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

328

1.16

0.36

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.43

0.35

1.5

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

245

1.18

0.35

1.9

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.40

0.35

1.2

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.40

0.35

1.0

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

661

1.11

0.34

1.2

1.3

1.4

1.5

g/l

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

254

0.83

0.34

1.4

1.3

56.3

65.6

0.61

208

(3008536) Aspergillus sp Ab [Presence] in Serum

154

1.23

0.33

2.1

2.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

182

1.21

0.33

1.3

1.1

96.7

79.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

219

1.19

0.33

3.8

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

219

1.19

0.33

3.7

2.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

388

1.13

0.32

1.9

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

201

1.19

0.32

1.8

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

474

1.12

0.31

2.7

2.9

41.2

38.7

0.43

174

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.35

0.31

1.7

3.4

—

0.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

649

1.09

0.29

1.6

1.5

11.7

11.9

umol/l

0.09

613

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

121

1.24

0.28

1.7

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

1.27

0.27

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

118

0.76

0.27

1.0

—

(4212803)

1.19

0.26

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

253

1.15

0.26

2.0

3.5

—

(40768800) Prostate Pathology biopsy report

151

1431

1.06

0.25

1.2

—

(21494434) Karyotype in Bone marrow

645

1.09

0.25

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.25

0.25

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

100

936

1.07

0.25

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

127

1199

1.06

0.25

2.4

2.8

36.1

1335.0

u/ml

0.95

121

1152

(3034092) Cytoplasmic Ig cells/100 cells in Blood

105

1.24

0.24

9.5

7.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

350

3388

1.03

0.24

1.3

1.4

—

(3014891) Appearance of Pleural fluid

0.73

0.24

2.2

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.28

0.23

1.2

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

990

0.94

0.22

1.2

1.4

2.5

4.0

ug/l

1.96

852

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.25

0.22

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.27

0.22

1.1

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

305

0.88

0.22

2.4

2.0

387.3

891.3

e6/l

1.76

204

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

6.8

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

3533

35071

1.01

0.21

2.8

2.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

344

1.11

0.21

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

105

0.76

0.21

2.6

3.8

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

174

1814

0.96

0.20

3.9

3.1

26.6

27.2

mg/l

0.07

1130

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.20

0.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.25

0.20

1.8

2.3

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.25

0.20

1.0

3.2

7.1

u/ml

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

183

1.15

0.20

1.3

1.2

63.6

72.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.22

0.20

1.5

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.20

0.19

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

384

1.09

0.19

1.2

1.1

1583.8

1509.6

miu/ml

0.13

384

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

496

5073

0.98

0.19

2.8

3.6

28.9

57.4

u/ml

3.66

482

4897

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

146

1.16

0.19

3.1

2.8

—

40.0

—

(3035880) pH of Pleural fluid

375

1.09

0.19

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

303

2944

1.03

0.19

3.2

3.8

96.8

1208.3

u/ml

2.72

261

2531

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.13

0.18

3.8

4.4

—

(40757373) Influenza virus identified in Isolate

143

0.84

0.18

1.4

1.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

138

1.16

0.17

1.8

2.0

—

(3045142) Bone marrow Pathology biopsy report

894

1.05

0.17

1.3

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

152

0.86

0.16

5.1

6.3

—

(3035933) Granulocytes/100 leukocytes in Blood

253

1.11

0.16

2.4

1.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

286

0.91

0.15

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.10

0.15

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

246

1.10

0.14

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

198

1.11

0.14

1.1

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

716

0.95

0.14

1.1

1.3

11.0

11.9

mmol/l

0.44

186

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

519

1.06

0.13

2.3

1.6

—

(40768441) Liver Pathology biopsy report

677

1.05

0.13

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

179

0.89

0.12

2.1

2.6

—

(4133840)

241

0.91

0.12

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

620

1.05

0.12

2.0

1.9

2.6

2.2

u/field

0.14

272

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

356

1.07

0.11

3.7

3.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

153

1.11

0.11

1.3

1.5

—

(3017509) Phencyclidine [Presence] in Urine

1.16

0.11

2.5

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

115

1.13

0.10

1.4

1.9

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

177

0.90

0.10

6.9

7.7

—

(44806420)

212

1.09

0.10

2.1

2.4

—

(4038314)

1.11

0.09

1.4

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.06

0.09

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.04

0.09

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.09

0.08

2.5

5.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

107

1.12

0.08

2.3

2.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.82

0.08

2.2

2.6

—

(3022475) Manganese [Moles/volume] in Blood

0.77

0.08

1.0

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.08

0.07

1.3

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

108

1.11

0.07

1.1

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

147

1.09

0.07

1.6

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.87

0.07

1.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.85

0.07

1.1

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

101

986

1.02

0.07

2.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

158

1.08

0.06

1.8

2.3

13.5

18.6

umol/l

1.95

158

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

182

0.93

0.05

1.8

1.9

3.5

ug/l

0.53

112

(40761539) Cells [Type] in Urine sediment by Light microscopy

192

0.94

0.05

1.1

1.2

—

(3024932) HLA-DR beta [Type]

317

1.04

0.05

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

606

1.02

0.04

7.3

6.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

572

0.98

0.03

1.4

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

209

0.96

0.03

1.4

1.1

—

(40768793) Breast Pathology biopsy report

218

2196

0.99

0.02

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

248

0.97

0.02

1.1

1.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

113

1.06

0.01

1.3

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

143

1.05

0.01

7.3

7.4

—

(3000034) Microalbumin [Mass/volume] in Urine

708

0.99

0.01

2.6

2.8

35.9

57.5

mg/l

0.52

511

(3002331) Protein [Mass/volume] in Peritoneal fluid

186

0.97

0.00

1.6

1.3

27.8

24.8

g/l

0.26

142

(3013727) Leukocytes other/100 leukocytes in Blood

264

1.02

0.00

2.6

3.6

49.2

52.5

0.35

252

(3029396) Erythrocyte agglutination [Presence] in Blood

186

1.02

0.00

2.7

3.0

—

(3024471) HLA-A [Type]

325

1.02

0.00

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

365

0.99

0.00

2.8

2.4

54.5

53.1

umol/l

0.09

307

(3009466) Valproate [Moles/volume] in Serum or Plasma

124

1241

1.00

0.00

4.2

5.6

359.1

376.7

umol/l

0.69

106

1075

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

331

1.00

0.00

1.1

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

269

1.00

0.00

2.3

1.8

9345.0

15513.4

e6/l

0.25

141

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

199

1.01

0.00

1.7

3.2

53.7

125.3

ng/l

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.00

0.00

1.0

1.5

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.00

0.00

1.0

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.1

—

2.6

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

200

1.00

0.00

6.4

7.6

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.6

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.94

0.00

1.1

1.2

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.4

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.2

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

17.4

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

100

1.00

0.00

1.2

1.5

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.0

26.0

—

6.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_ENTESOPATHYLOW and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_ENTESOPATHYLOW	0.924 [0.83, 1.03]	0.142
Birth year	1.0 [0.99, 1.01]	0.986

During the follow-up period (1.1.1998 — 31.12.2019), 2072 out of 26588 females with M13_ENTESOPATHYLOW died.

Males

Parameter	HR [95% CI]	p-value
M13_ENTESOPATHYLOW	0.863 [0.78, 0.96]	0.005
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 1895 out of 21564 males with M13_ENTESOPATHYLOW died.

Mortality risk

Mortality risk for people of age

years, who have M13_ENTESOPATHYLOW.

N-year risk	Females	Males
1	0.108%	0.118%
5	0.637%	0.87%
10	1.641%	2.381%
15	3.086%	4.737%
20	5.409%	8.139%

Relationships between endpoints

↥

Index endpoint: M13_ENTESOPATHYLOW – Enthesopathies of lower limb, excluding foot

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Enthesopathies of lower limb, excluding foot

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints